Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
J Hypertens
    October 2024
  1. RING A, Lo DF
    Assessing coffee's impact on blood pressure: a critical examination of measurement and cultural variations.
    J Hypertens. 2024;42:1834-1836.
    >> Share

  2. MOTIEJUNAITE J, de Pinho NA, Flamant M, Vidal-Petiot E, et al
    Reply to 'Unmasking hypertension in patients with CKD: who to screen and how to confirm the diagnosis?'.
    J Hypertens. 2024;42:1833-1834.
    >> Share

  3. QUARTI-TREVANO F, Mancia G, Grassi G
    Assessing the association between coffee consumption and blood pressure values: when complexity prevails.
    J Hypertens. 2024;42:1832-1833.
    >> Share

  4. GEORGIANOS PI, Vaios V, Karligkiotis A, Liakopoulos V, et al
    Unmasking hypertension in patients with chronic kidney disease: who to screen and how to confirm the diagnosis?
    J Hypertens. 2024;42:1831-1832.
    >> Share

  5. KIM H, Lichtenstein AH, Coresh J, Appel LJ, et al
    Serum protein responses to Dietary Approaches to Stop Hypertension (DASH) and DASH-Sodium trials and associations with blood pressure changes.
    J Hypertens. 2024;42:1823-1830.
    >> Share

  6. RUIZ-SANCHEZ JG, Fernandez Sanchez A, Cardenas-Salas J, Fernandez-Cagigao Y, et al
    Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.
    J Hypertens. 2024;42:1813-1822.
    >> Share

  7. REBOLDI G, Angeli F, Verdecchia P
    Antihypertensive drugs in the morning or the evening? A complicated question with no clear answer.
    J Hypertens. 2024;42:1684-1686.
    >> Share

  8. LEE EK, Wang S, Ng WL, Ramdzan SN, et al
    Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials.
    J Hypertens. 2024;42:1653-1664.
    >> Share

  9. SATOH M, Metoki H, Kikuya M, Murakami T, et al
    Proposal of reference value for day-to-day blood pressure variability based on two outcomes: the Ohasama study.
    J Hypertens. 2024;42:1769-1776.
    >> Share

  10. PAN X, Chen Y, Yang Y, Kidambi S, et al
    Mediating effects of BMI on the association between DNA methylation regions and 24-h blood pressure in African Americans.
    J Hypertens. 2024;42:1750-1756.
    >> Share

  11. TABARA Y, Matsumoto T, Murase K, Setoh K, et al
    Sleep blood pressure measured using a home blood pressure monitor was independently associated with cardiovascular disease incidence: the Nagahama study.
    J Hypertens. 2024;42:1695-1702.
    >> Share

    September 2024
  12. CONNOLLY BJ, Saxton SN
    Recent updates on the influence of iron and magnesium on vascular, renal, and adipose inflammation and possible consequences for hypertension.
    J Hypertens. 2024 Sep 10. doi: 10.1097/HJH.0000000000003829.
    >> Share

  13. KARIO K, Williams B, Tomitani N, McManus RJ, et al
    Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin Amer
    J Hypertens. 2024 Sep 9. doi: 10.1097/HJH.0000000000003827.
    >> Share

  14. BAHAT G, Ribeiro H, Sheppard JP, Bogaerts JMK, et al
    Twelve hot questions in the management of hypertension in patients aged 80+ years and their answers with the help of the 2023 European Society of Hypertension Guidelines.
    J Hypertens. 2024 Sep 5. doi: 10.1097/HJH.0000000000003844.
    >> Share

  15. DOKU A, Asamoah KT, Amaechi MU, Auala T, et al
    The development of Africa's first unified hypertension management guidelines.
    J Hypertens. 2024 Sep 2. doi: 10.1097/HJH.0000000000003864.
    >> Share

  16. KAZIBWE R, Muhammad AI, Singleton MJ, Evans JK, et al
    Self-rated health and risk of incident cardiovascular events among individuals with hypertension.
    J Hypertens. 2024;42:1573-1580.
    >> Share

  17. GREENSTEIN AS
    Don't forget to check your blood pressure.
    J Hypertens. 2024;42:1528.
    >> Share

  18. COTTRELL EC
    Commentary on: 'Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes'.
    J Hypertens. 2024;42:1523-1524.
    >> Share

  19. RUBIN S, Tomaszewski M
    Self-rated health in hypertension: navigating the complexities of cardiovascular risk prediction.
    J Hypertens. 2024;42:1521-1522.
    >> Share

  20. SALUJA S, Darlay R, Lennon R, Keavney BD, et al
    Whole -genome survival analysis of 144 286 people from the UK Biobank identifies novel loci associated with blood pressure.
    J Hypertens. 2024;42:1647-1652.
    >> Share

  21. ZHANG W, Li QY, Guo ZH, Zhang CY, et al
    Report on three cases of familial primary aldosteronism type IV.
    J Hypertens. 2024;42:1641-1646.
    >> Share

  22. HINDERLITER AL, Lin FC, Yang Y, Viera LA, et al
    The utility of home blood pressure load in predicting average self-measured blood pressure.
    J Hypertens. 2024;42:1624-1631.
    >> Share

  23. OMBONI S, Alfie J, Arystan A, Avolio A, et al
    Association of 24-h central hemodynamics and stiffness with cardiovascular events and all-cause mortality. The VASOTENS Registry.
    J Hypertens. 2024;42:1590-1597.
    >> Share

    August 2024
  24. AIZAWA K, Jordan AN, Gooding KM, Llewellyn DJ, et al
    Aortic reservoir-excess pressure parameters are associated with worse cognitive function in people with untreated stage II/III hypertension.
    J Hypertens. 2024 Aug 30. doi: 10.1097/HJH.0000000000003853.
    >> Share

  25. WANG X, Shaw JE, Yu J, Jennings G, et al
    Prevalence, awareness, treatment, and control rates of hypertension in the general population of Australia: a systematic review and meta-analysis.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003854.
    >> Share

  26. FERRARI R, Carpes LO, Domingues LB, Schneider VM, et al
    Recreational beach tennis training reduces ambulatory blood pressure in adults with hypertension: a randomized clinical trial.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003850.
    >> Share

  27. ASHENAGAR MS, Higashino T, Matsumoto A, Higashino H, et al
    Mechanisms of thiazide-induced hypertension treatment: insights from gene expression and histological analysis in malignant stroke-prone spontaneously hypertensive rats.
    J Hypertens. 2024 Aug 22. doi: 10.1097/HJH.0000000000003837.
    >> Share

  28. FRANCHI M, Torrigiani G, Kjeldsen SE, Mancia G, et al
    Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study.
    J Hypertens. 2024 Aug 14. doi: 10.1097/HJH.0000000000003841.
    >> Share

  29. KOVELL LC, Denu M, Revoori R, Sadaniantz K, et al
    Barriers and facilitators to home blood pressure monitoring in women with pregnancies complicated by hypertensive disorders: a qualitative study.
    J Hypertens. 2024 Aug 12. doi: 10.1097/HJH.0000000000003835.
    >> Share

  30. BAVARESCO GAMBASSI B, Schwingel PA
    Dynamic power training combined with endurance training reduces arterial stiffness and improves hemodynamic parameters in older adults diagnosed with grade 1 hypertension?
    J Hypertens. 2024;42:1461-1462.
    >> Share

  31. SALUJA S
    Reflections on the 2023 European Society of Hypertension summer school: a participant's perspective.
    J Hypertens. 2024;42:1460-1461.
    >> Share

  32. MA X, Zhuo Y, Zhang Z, Yang Y, et al
    Association of T-cell receptor repertoires and arterial stiffness in patients with essential hypertension.
    J Hypertens. 2024;42:1440-1448.
    >> Share

  33. DUPREZ DA, Jacobs DR Jr
    Hypertension and OMICS, quo vadis.
    J Hypertens. 2024;42:1307-1308.
    >> Share

  34. ZHANG Y, Sun Q, Yu C, Sun D, et al
    Associations of traditional cardiovascular risk factors with 15-year blood pressure change and trajectories in Chinese adults: a prospective cohort study.
    J Hypertens. 2024;42:1340-1349.
    >> Share

    July 2024
  35. NEMCSIK J, Takacs J, Kekk Z, Farsang C, et al
    White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry.
    J Hypertens. 2024 Jul 30. doi: 10.1097/HJH.0000000000003825.
    >> Share

  36. BOSCH A, Rauh M, Striepe K, Schiffer M, et al
    Renal adaptation in pre-obesity patients with hypertension.
    J Hypertens. 2024 Jul 22. doi: 10.1097/HJH.0000000000003821.
    >> Share

  37. SANCHEZ RA, Sanchez MJ, Pessana F, Ramirez AJ, et al
    Insulin resistance is associated to future hypertension in normotensive salt-sensitive individuals: a 10-year follow-up study.
    J Hypertens. 2024 Jul 15. doi: 10.1097/HJH.0000000000003810.
    >> Share

  38. LARKINS NG, Choong C, Schlaich M, Quinlan C, et al
    Defining childhood hypertension: is it too complicated? An evaluation of the potential impact of different approaches in an Australian paediatric population.
    J Hypertens. 2024 Jul 15. doi: 10.1097/HJH.0000000000003815.
    >> Share

  39. YAMANAKA K, Suzuki M, Pham LT, Tomita K, et al
    Involvement of D1 dopamine receptor in the nucleus of the solitary tract of rats in stress-induced hypertension and exercise.
    J Hypertens. 2024 Jul 5. doi: 10.1097/HJH.0000000000003809.
    >> Share

  40. KOS M, Nad T, Stupin A, Drenjancevic I, et al
    Juvenile primary hypertension is associated with attenuated macro- and microvascular dilator function independently of body weight.
    J Hypertens. 2024 Jul 5. doi: 10.1097/HJH.0000000000003812.
    >> Share

  41. MUNTNER P, Shimbo D, Schwartz JE
    Does nondipping blood pressure provide prognostic information for all-cause and cardiovascular mortality independent of nighttime blood pressure?
    J Hypertens. 2024;42:1151-1153.
    >> Share

  42. SAXENA M
    Vaccines against angiotensin receptors as a potential treatment for hypertension.
    J Hypertens. 2024;42:1150.
    >> Share

  43. SALUJA S, Lennon R
    Exploring novel therapeutic opportunities for hypertension: a paradigm-shifting approach via integrative multiomic analysis, pioneering the path to precision medicine.
    J Hypertens. 2024;42:1147-1149.
    >> Share

  44. MESSERLI FH, Schoenenberger-Berzins R, Messerli AW
    Why the lack of enthusiasm for renal denervation?
    J Hypertens. 2024;42:1145-1146.
    >> Share

  45. MANCIA G, Schumacher H, Bohm M, Grassi G, et al
    Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes.
    J Hypertens. 2024;42:1269-1281.
    >> Share

  46. AF GEIJERSTAM P, Radholm K, Jonasson L, Lindahl TL, et al
    P-selectin and C-reactive protein in relation to home blood pressure and coronary calcification: a SCAPIS substudy.
    J Hypertens. 2024;42:1226-1234.
    >> Share

  47. DE LA SIERRA A, Staplin N, Ruilope LM, Gorostidi M, et al
    A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortality.
    J Hypertens. 2024;42:1197-1202.
    >> Share

    June 2024
  48. SUN Y, Qi X, Wang X, Lin X, et al
    Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset.
    J Hypertens. 2024 Jun 26. doi: 10.1097/HJH.0000000000003803.
    >> Share

  49. YAP HJ, Lim JJJ, Tan SD, Ang CS, et al
    Effectiveness of digital health interventions on adherence and control of hypertension: a systematic review and meta-analysis.
    J Hypertens. 2024 Jun 25. doi: 10.1097/HJH.0000000000003793.
    >> Share

  50. PHAM MHC, Kuhl JT, Fuchs A, Sigvardsen PE, et al
    Determinants of thoracic aortic size in normotensive and hypertensive individuals.
    J Hypertens. 2024 Jun 25. doi: 10.1097/HJH.0000000000003792.
    >> Share

  51. KOH S, Kim D, Kim M, Kim T, et al
    Aerobic exercise effects on systolic blood pressure and endothelial inflammation in obese and non-obese elderly women with isolated systolic hypertension.
    J Hypertens. 2024 Jun 20. doi: 10.1097/HJH.0000000000003794.
    >> Share

  52. WANG J, Xu Y, Zhu J, Wu B, et al
    Multimodal data-driven, vertical visualization prediction model for early prediction of atherosclerotic cardiovascular disease in patients with new-onset hypertension.
    J Hypertens. 2024 Jun 18. doi: 10.1097/HJH.0000000000003798.
    >> Share

  53. WOJCIECHOWSKA W, Rajzer M, Kreutz R, Weber T, et al
    The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).
    J Hypertens. 2024 Jun 13. doi: 10.1097/HJH.0000000000003752.
    >> Share


  54. Dietary factors and hypertension risk in West Africa: a systematic review and meta-analysis of observational studies: Erratum.
    J Hypertens. 2024;42:1108.
    >> Share

  55. PEETERS LEJ, Koch BCP, Versmissen J
    Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.
    J Hypertens. 2024;42:1106-1107.
    >> Share

  56. RUBIN D, Lo DF, Jammula S, Carroll N, et al
    Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
    J Hypertens. 2024;42:1105-1106.
    >> Share

  57. MINETTO J, Cuello MB, Dominici FP, Caniffi C, et al
    Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension.
    J Hypertens. 2024;42:1101-1104.
    >> Share

  58. ZHOU YF, Ye YX, Chen JX, Zhang YB, et al
    Circulating metabolic biomarkers and risk of new-onset hypertension: findings from the UK Biobank.
    J Hypertens. 2024;42:1066-1074.
    >> Share

  59. CAMARGO LL, Trevelin SC, da Silva GHG, Dos Santos Dias AA, et al
    Protein disulfide isomerase-mediated transcriptional upregulation of Nox1 contributes to vascular dysfunction in hypertension.
    J Hypertens. 2024;42:984-999.
    >> Share

  60. KREUTZ R, Brunstrom M, Burnier M, Grassi G, et al
    Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern.
    J Hypertens. 2024;42:966-967.
    >> Share

  61. CHARCHAR FJ
    Wake up and enjoy the coffee without worrying about your blood pressure!
    J Hypertens. 2024;42:965.
    >> Share

  62. LATOSINSKA A, Siwy J, Mischak H
    Multiomics: paving the path towards personalized prevention of hypertension.
    J Hypertens. 2024;42:962-964.
    >> Share

  63. RUILOPE LM
    Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'.
    J Hypertens. 2024;42:961.
    >> Share

  64. TREVANO FQ, Vela-Bernal S, Facchetti R, Cuspidi C, et al
    Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study.
    J Hypertens. 2024;42:1094-1100.
    >> Share

  65. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
    Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
    J Hypertens. 2024;42:1009-1018.
    >> Share

  66. KOKKO E, Choudhary MK, Mutanen A, Honkonen M, et al
    Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study.
    J Hypertens. 2024;42:1057-1065.
    >> Share

  67. VRIEND EMC, Bouwmeester TA, Franco OH, Galenkamp H, et al
    Sex differences in blood pressure phenotypes over time - the HELIUS study.
    J Hypertens. 2024;42:977-983.
    >> Share

    May 2024
  68. XU J, Wang JJ, Zhao QH, Gong SG, et al
    Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension.
    J Hypertens. 2024 May 28. doi: 10.1097/HJH.0000000000003782.
    >> Share

  69. ZEIJEN VJM, Peeters LEJ, Asman A, Boersma E, et al
    Quality-of-life and beliefs about medication in relation to a therapy adherence intervention in resistant hypertension: the Resistant HYpertension: MEasure to ReaCh Targets trial.
    J Hypertens. 2024 May 24. doi: 10.1097/HJH.0000000000003780.
    >> Share

  70. ZHAO H, Wen P, Xu Q, Zi Y, et al
    Association of sleep traits with risk of hypertensive disorders of pregnancy: a mendelian randomization study.
    J Hypertens. 2024 May 22. doi: 10.1097/HJH.0000000000003771.
    >> Share

  71. GRASSI G
    Thirty-five years of the European Society of Hypertension: from past to future.
    J Hypertens. 2024 May 22. doi: 10.1097/HJH.0000000000003778.
    >> Share

  72. DORDEVIC DB, Koracevic GP, Dordevic AD, Lovic DB, et al
    Hypertension and left ventricular hypertrophy.
    J Hypertens. 2024 May 16. doi: 10.1097/HJH.0000000000003774.
    >> Share

  73. SCHLAICH MP, Tsioufis K, Taddei S, Ferri C, et al
    Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003769.
    >> Share

  74. SHAHRBABAKI SS, Liu X, Baumert M
    Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003775.
    >> Share

  75. HALIMI JM, Sarafidis P, Azizi M, Bilo G, et al
    Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire.
    J Hypertens. 2024 May 14. doi: 10.1097/HJH.0000000000003756.
    >> Share

  76. ROSSI GP, Bagordo D, Rossi FB, Pintus G, et al
    'Essential' arterial hypertension: time for a paradigm change.
    J Hypertens. 2024 May 9. doi: 10.1097/HJH.0000000000003767.
    >> Share

  77. CHEN Z, Wei D, Zhao M, Shi J, et al
    Associations of serum glucocorticoid levels on hypertension and blood pressure-related indicators: a nested case-control study in rural China.
    J Hypertens. 2024 May 8. doi: 10.1097/HJH.0000000000003758.
    >> Share

  78. HUA D, Huang W, Huang W, Xie Q, et al
    TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
    J Hypertens. 2024 May 2. doi: 10.1097/HJH.0000000000003748.
    >> Share

  79. CASIGLIA E
    AND, OR, AND/OR in hypertension guidelines.
    J Hypertens. 2024;42:934-935.
    >> Share

  80. HUTCHINGS DC, Heagerty AM
    Sleeping unsoundly: CPAP and its complexities in treating sleep apnoea hypertension.
    J Hypertens. 2024;42:766-767.
    >> Share

  81. BRASIL IA, Silva JCPL, Pescatello LS, Farinatti P, et al
    Central and peripheral mechanisms underlying postexercise hypotension: a scoping review.
    J Hypertens. 2024;42:751-763.
    >> Share

  82. WANG S, Wong SYS, Yip BHK, Lee EKP, et al
    Age-dependent association of central blood pressure with cardiovascular outcomes: a cohort study involving 34 289 participants using the UK biobank.
    J Hypertens. 2024;42:769-776.
    >> Share

  83. CELLER BG, Yong A, Rubenis I, Butlin M, et al
    Accurate detection of Korotkoff sounds reveals large discrepancy between intra-arterial systolic pressure and simultaneous noninvasive measurement of blood pressure with brachial cuff sphygmomanometry.
    J Hypertens. 2024;42:873-882.
    >> Share

  84. NATALE P, Palmer SC, Jaure A, Saglimbene V, et al
    Blood pressure lowering for kidney transplant recipients: systematic review with network meta-analysis.
    J Hypertens. 2024;42:848-855.
    >> Share

  85. SESA-ASHTON G, Carnagarin R, Nolde JM, Muente I, et al
    Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation.
    J Hypertens. 2024;42:922-927.
    >> Share

    April 2024
  86. WANG JG, Topouchian J, Bricout-Hennel S, Mu J, et al
    Efficacy and safety of a single-pill versus free combination of perindopril/indapamide/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension.
    J Hypertens. 2024 Apr 25. doi: 10.1097/HJH.0000000000003741.
    >> Share

  87. XU ZQ, Li XZ, Zhu R, Ge R, et al
    Asprosin contributes to vascular remodeling in hypertensive rats via superoxide signaling.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003751.
    >> Share

  88. FARAH BQ, Forjaz CLM, O'Driscoll JM, Millar PJ, et al
    Characteristics associated with responsiveness to isometric handgrip training in medicated hypertensive patients: secondary data analysis.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003749.
    >> Share

  89. HUGHES AD, Davey Smith G, Howe LD, Lawlor D, et al
    Differences between brachial and aortic blood pressure in adolescence and their implications for diagnosis of hypertension.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003743.
    >> Share

  90. CHE J, Tong J, Kuang X, Zheng C, et al
    Hyperuricemia and gout enhanced the risk of long-term mortality in hypertension: insights from the National Health and Nutrition Examination Survey 2007-2018.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003744.
    >> Share

  91. SHANTSILA E, Beevers DG, Lip GYH
    For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003733.
    >> Share

  92. SHARP ASP, Sanderson A, Hansell N, Reddish K, et al
    Renal denervation for uncontrolled hypertension: a systematic review and meta-analysis examining multiple subgroups.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003727.
    >> Share

  93. THOMOPOULOS C, Hitij JB, De Backer T, Gkaliagkousi E, et al
    Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003739.
    >> Share

  94. PALERMITI A, Pappaccogli M, Rabbia F, D'Avolio A, et al
    Multiple drug intolerance in antihypertensive patients: what is known and what is missing.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003737.
    >> Share

  95. SASON A, Adelson M, Leshno D, Schreiber S, et al
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024 Apr 11. doi: 10.1097/HJH.0000000000003740.
    >> Share

  96. KYRIAKOULIS KG, Kollias A, Bilo G, Soranna D, et al
    Blood pressure variability assessed by office, home, and ambulatory measurements before and during antihypertensive drug treatment: a sub-analysis of the REVERENT randomized trial.
    J Hypertens. 2024 Apr 5. doi: 10.1097/HJH.0000000000003730.
    >> Share

  97. KEISER T, Katz S, Robson SM, Greaney JL, et al
    Association between time-of-day for eating, exercise, and sleep with blood pressure in adults with elevated blood pressure or hypertension: a systematic review.
    J Hypertens. 2024 Apr 3. doi: 10.1097/HJH.0000000000003732.
    >> Share

  98. BAVARESCO GAMBASSI B, Chaves LFC, Sousa TMDS, Ribeiro MJS, et al
    Short-duration dynamic power training with elastic bands combined with endurance training: a promising approach to hypertension management in older adults.
    J Hypertens. 2024;42:735-742.
    >> Share

  99. FERREIRA MJ, Dias DDS, Silva GDC, de Araujo AA, et al
    Concurrent exercise training potentiates the effects of angiotensin-converting enzyme inhibitor on regulatory systems of blood pressure control in ovariectomized hypertensive rats.
    J Hypertens. 2024;42:650-661.
    >> Share

  100. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals.
    J Hypertens. 2024;42:610-619.
    >> Share

  101. SALUJA S
    A critical commentary on the use of combined power and endurance training for hypertension management in older adults.
    J Hypertens. 2024;42:605-606.
    >> Share

  102. BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
    Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus.
    J Hypertens. 2024;42:583-593.
    >> Share

  103. ZHOU T, Gu S, Shao F, Li P, et al
    Prediction of preeclampsia from retinal fundus images via deep learning in singleton pregnancies: a prospective cohort study.
    J Hypertens. 2024;42:701-710.
    >> Share

  104. ASTUDILLO Y, Kibrom S, Pereira T, Solomon S, et al
    Association between anxiety and elevated blood pressure in adolescent patients: a single-center cross-sectional study.
    J Hypertens. 2024;42:644-649.
    >> Share

  105. WADA A, Kabayama M, Godai K, Kido M, et al
    Factors influencing the continuation of home blood pressure measurement in community-dwelling older adults: the NOSE study.
    J Hypertens. 2024;42:694-700.
    >> Share

    March 2024
  106. MAVROGEORGIS E, Kondyli M, Mischak H, Vlahou A, et al
    Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
    J Hypertens. 2024 Mar 29. doi: 10.1097/HJH.0000000000003726.
    >> Share

  107. BERILLO O, Comeau K, Caillon A, Leclerc S, et al
    CD28-expressing delta T cells are increased in perivascular adipose tissue of hypertensive mice and in subcutaneous adipose tissue of obese humans.
    J Hypertens. 2024 Mar 27. doi: 10.1097/HJH.0000000000003725.
    >> Share

  108. LIN J, Costa JO, Pearson SA, Buckley NA, et al
    Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia.
    J Hypertens. 2024 Mar 14. doi: 10.1097/HJH.0000000000003721.
    >> Share

  109. WANG Z, Li W, Jiang C, Wang J, et al
    Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003715.
    >> Share

  110. WU J, Wu Z, Kuang W, Shi D, et al
    Combined vaccines against angiotensin II receptor type 1 and alpha 1D-adrenergic receptor for hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003710.
    >> Share

  111. GUO J, Jia P, Gu Z, Tang W, et al
    Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003716.
    >> Share

  112. PALATINI P, Kollias A, Saladini F, Asmar R, et al
    Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2024 Mar 4. doi: 10.1097/HJH.0000000000003704.
    >> Share

  113. WATZ MES, Tivesten A, Ottarsdottir K, Li Y, et al
    Reply on: Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:580-581.
    >> Share

  114. PATEL J, Amin K, Lo DF
    Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:579-580.
    >> Share

  115. ZHENG X, Lei Y, Cheng XW
    Resolvin D1 as a novel target in the management of hypertension.
    J Hypertens. 2024;42:393-395.
    >> Share

  116. KOLLIAS A, Kyriakoulis KG, Komnianou A, Stathopoulou P, et al
    Prognostic value of home versus ambulatory blood pressure monitoring: a systematic review and meta-analysis of outcome studies.
    J Hypertens. 2024;42:385-392.
    >> Share

  117. NAITO Y, Yasumura S, Okuno K, Asakura M, et al
    Hypoxia-inducible factor-prolyl hydroxylase inhibitor Roxadustat (FG-4592) reduces renal fibrosis in Dahl salt-sensitive rats.
    J Hypertens. 2024;42:497-505.
    >> Share

  118. LOO G, Puar T, Foo R, Ong TK, et al
    Unique characteristics of Asians with hypertension: what is known and what can be done?
    J Hypertens. 2024 Mar 1. doi: 10.1097/HJH.0000000000003706.
    >> Share

    February 2024
  119. BERSCH-FERREIRA AC, Machado RHV, de Oliveira JS, Santos RHN, et al
    Effectiveness of a two-component nutritional strategy for blood pressure control in individuals with hypertension users of a public health system: a randomized controlled clinical trial.
    J Hypertens. 2024 Feb 26. doi: 10.1097/HJH.0000000000003703.
    >> Share

  120. LANG X, Peng C, Zhang Y, Gao R, et al
    Correlation between systolic blood pressure and mortality in heart failure patients with hypertension.
    J Hypertens. 2024 Feb 16. doi: 10.1097/HJH.0000000000003693.
    >> Share

  121. CARRY BJ, Miller WL
    Blood volume phenotypes and patient sex in resistant hypertension.
    J Hypertens. 2024 Feb 15. doi: 10.1097/HJH.0000000000003688.
    >> Share

  122. LEGRAND F, Motiejunaite J, Arnoult F, Lahens A, et al
    Prevalence and factors associated with masked hypertension in chronic kidney disease.
    J Hypertens. 2024 Feb 12. doi: 10.1097/HJH.0000000000003680.
    >> Share

  123. RAMIREZ-CARRACEDO R, Hernandez I, Moreno-Gomez-Toledano R, Diez-Mata J, et al
    NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.
    J Hypertens. 2024 Feb 6. doi: 10.1097/HJH.0000000000003679.
    >> Share

  124. CHUNNAN L, Shaomei S, Wannian L
    Sleep and risk of hypertension in general American adults: reply.
    J Hypertens. 2024;42:382-383.
    >> Share

  125. SCORZA FA, Bombardi LM, de Almeida AG, Finsterer J, et al
    Hypertension: the dramatic rise in dangerous pesticides found on fruits and vegetables.
    J Hypertens. 2024;42:381-382.
    >> Share

  126. GUAN T, Cao M, Zheng C, Zhou H, et al
    Dose-response association between physical activity and blood pressure among Chinese adults: a nationwide cross-sectional study.
    J Hypertens. 2024;42:360-370.
    >> Share

  127. FRAVEL MA, Ernst ME, Woods RL, Beilin L, et al
    Long-term blood pressure variability and frailty risk in older adults.
    J Hypertens. 2024;42:244-251.
    >> Share

  128. KARELIUS S, Pentti J, Juhanoja E, Jula A, et al
    Association of work-related psychosocial factors and day-to-day home blood pressure variation: the Finn-Home study.
    J Hypertens. 2024;42:337-343.
    >> Share

  129. NEWTON J, Haseler E, Higgins C, Futcher C, et al
    Reliability of systolic blood pressure measured by parents in young children at home using a hand held doppler device and aneroid sphygmomanometer.
    J Hypertens. 2024;42:308-314.
    >> Share

  130. ZAMAN S, Raj IS, Yang AWH, Lindner R, et al
    Exercise training reduces arterial stiffness in women with high blood pressure: a systematic review and meta-analysis.
    J Hypertens. 2024;42:197-204.
    >> Share

  131. LIU N, Gong Z, Li Y, Xu Y, et al
    CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats.
    J Hypertens. 2024;42:315-328.
    >> Share

  132. MARQUES ER, Bernardino AC, Alvim RO, Schreiber R, et al
    Relationship of blood pressure measured in the calf with arm blood pressure and arterial stiffness: a general population study.
    J Hypertens. 2024;42:301-307.
    >> Share

  133. ZHANG L, Wang W, Gong J, Wang X, et al
    Development, validation, and clinical utility of a risk prediction model for recurrent preeclampsia.
    J Hypertens. 2024;42:236-243.
    >> Share

    January 2024
  134. SAGARA K, Goto K, Maeda M, Murata F, et al
    Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the life study.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003661.
    >> Share

  135. YE XF, Wang WY, Wang XY, Huang QF, et al
    Seasonal variation in ambulatory blood pressure control in patients on clinic blood pressure-guided antihypertensive treatment.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003666.
    >> Share

  136. EGAN BM, Li J, Sutherland SE, Rakotz MK, et al
    Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003656.
    >> Share

  137. KIM BS, Lee Y, Shin JH, Heo R, et al
    Blood pressure and variability responses to the down-titration of antihypertensive drugs.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003668.
    >> Share

  138. OKEKUNLE AP, Asowata OJ, Akpa OM, Fakunle AG, et al
    Dietary patterns associated with hypertension among stroke-free indigenous Africans: insights from the Stroke Investigative Research and Educational Network study.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003662.
    >> Share


  139. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Asso
    J Hypertens. 2024;42:194.
    >> Share

  140. ABDELAZEEM B, Saleh O, Mahmoud A, Abuelazm M, et al
    Authors' response to "Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings".
    J Hypertens. 2024;42:191-192.
    >> Share

  141. FERNANDEZ JR, Mojon A, Smolensky MH, Hermida RC, et al
    Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings.
    J Hypertens. 2024;42:190-191.
    >> Share

  142. KREUTZ R, Palatini P, Stergiou G, Mancia G, et al
    Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?
    J Hypertens. 2024;42:188-189.
    >> Share

  143. PAIVA AMG, Gomes MICM, Silva EAA, Feitosa ADM, et al
    Should arm positioning matter in the diagnosis of orthostatic hypotension and hypertension?
    J Hypertens. 2024;42:186-188.
    >> Share

  144. ARMANINI D, Sabbadin C, Manso J, Boscaro M, et al
    Consideration in the evaluation of follow-up of resistant hypertension.
    J Hypertens. 2024;42:56-57.
    >> Share

  145. OSCULLO G, Gomez-Olivas JD, Martinez-Garcia MA
    Nocturnal hypertension phenotypes and obstructive sleep apnoea.
    J Hypertens. 2024;42:50-52.
    >> Share

  146. RABBITT L, Curneen J, Hobbins A, Browne D, et al
    A cost-analysis of managing secondary and apparent treatment-resistant hypertension in a specialist multidisciplinary hypertension clinic.
    J Hypertens. 2024;42:58-69.
    >> Share

  147. KISHI T
    Gender differences in the association of serum uric acid with left ventricular hypertrophy should be focused.
    J Hypertens. 2024;42:53-55.
    >> Share

  148. OSMAN MMA, Mullins E, Kleprlikova H, Wilkinson IB, et al
    Beetroot juice, exercise, and cardiovascular function in women planning to conceive.
    J Hypertens. 2024;42:101-108.
    >> Share

  149. SNYMAN JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, et al
    A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    J Hypertens. 2024;42:136-142.
    >> Share

  150. SHANTSILA E, Shantsila A, Williams N, Lip GYH, et al
    Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.
    J Hypertens. 2024;42:95-100.
    >> Share

  151. GHERBESI E, Faggiano A, Sala C, Carugo S, et al
    Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies.
    J Hypertens. 2024;42:109-117.
    >> Share

  152. PANAGIOTAKOS D, Antza C, Kotsis V
    Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies.
    J Hypertens. 2024;42:1-9.
    >> Share

    December 2023
  153. GIBSON R, Aljuraiban GS, Oude-Griep LM, Vu TH, et al
    Relationship of calcium and magnesium intakes with the dietary approaches to stop hypertension score and blood pressure: the International Study of Macro/micronutrients and Blood Pressure.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003648.
    >> Share

  154. GAN J, Shi Y, Zhao R, Li D, et al
    Adipose c-Jun NH2-terminal kinase promotes angiotensin II-induced and deoxycorticosterone acetate salt-induced hypertension and vascular dysfunction by inhibition of adiponectin production and activation of SGK1 in mice.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003649.
    >> Share

  155. WANG L, Li C, Li Z, Li Q, et al
    Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003650.
    >> Share

  156. SERRA MO, de Macedo LR, Silva M, Lautner RQ, et al
    Effect of Vitamin D supplementation on blood pressure in hypertensive individuals with hypovitaminosis D: a systematic review and meta-analysis.
    J Hypertens. 2023 Dec 19. doi: 10.1097/HJH.0000000000003646.
    >> Share

  157. SATHEESH G, Dhurjati R, Huffman MD, Rosende A, et al
    Standardized treatment protocols for hypertension: global availability, characteristics, and alignment with the hypertension guideline recommendations.
    J Hypertens. 2023 Dec 18. doi: 10.1097/HJH.0000000000003636.
    >> Share

  158. SALMAN UA, Schwartz JG, McMahan AC, Michalek JE, et al
    Rapid Gastric emptying in spontaneously hypertensive rats.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003640.
    >> Share

  159. SASAGAWA Y, Inoue Y, Futagami K, Nakamura T, et al
    Application of deep neural survival networks to the development of risk prediction models for diabetes mellitus, hypertension, and dyslipidemia.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003626.
    >> Share

  160. CIFKOVA R, Harazny JM, Bruthans J, Wohlfahrt P, et al
    Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003637.
    >> Share

  161. CRUZ-LOPEZ EO, Ye D, Stolk DG, Clahsen-van Groningen MC, et al
    Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effects.
    J Hypertens. 2023 Dec 11. doi: 10.1097/HJH.0000000000003633.
    >> Share

  162. ATASOY S, Henningsen P, Johar H, Middeke M, et al
    Hypertension in the first blood pressure reading and the risk of cardiovascular disease mortality in the general population: findings from the prospective KORA study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003629.
    >> Share

  163. KIM Y, Kim J, Kang E, Im DW, et al
    The association of time-updated ambulatory blood pressure and renal progression in hypertensive patients with chronic kidney disease: post hoc analysis of ACCURATE study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003625.
    >> Share

  164. BOTHE TL, Kreutz R, Glos M, Patzak A, et al
    Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003632.
    >> Share

  165. THOMOPOULOS C
    Target blood pressure in isolated systolic hypertension: a meta-analysis of randomized outcome trials.
    J Hypertens. 2023;41:2113-2114.
    >> Share

  166. RAM CVS
    The latest hypertension guidelines: from encryption to decryption, finally!
    J Hypertens. 2023;41:2072-2073.
    >> Share

    November 2023
  167. NAKAGAWA K, Chen R, Ross GW, Donlon TA, et al
    FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk.
    J Hypertens. 2023 Nov 23. doi: 10.1097/HJH.0000000000003620.
    >> Share

  168. XIONG Y, He Y, Chen Z, Wu T, et al
    Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.
    J Hypertens. 2023 Nov 17. doi: 10.1097/HJH.0000000000003613.
    >> Share

  169. HALE G, Puchades E, Jacomino G, El-Mcharfie L, et al
    Use trends of chlorthalidone and hydrochlorothiazide among United States adults with hypertension: National Health and Nutrition Examination Survey 2009-2018.
    J Hypertens. 2023 Nov 16. doi: 10.1097/HJH.0000000000003622.
    >> Share

  170. KIM JH, Joo HJ, Chung SH, Yum Y, et al
    Cardiovascular outcomes according to on-treatment systolic blood pressure in older hypertensive patients: a multicenter cohort using a common data model.
    J Hypertens. 2023 Nov 15. doi: 10.1097/HJH.0000000000003544.
    >> Share

  171. BUDZYN M, Gryszczynska B, Begier-Krasinska B, Kaja E, et al
    Decreased toll-like receptor 4 and CD11b/CD18 expression on peripheral monocytes of hypertensive patients correlates with a lesser extent of endothelial damage: a preliminary study.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003617.
    >> Share

  172. JOYCE OC, McHugh C, Mockler D, Wilson F, et al
    Midlife hypertension is a risk factor for some, but not all, domains of cognitive decline in later life: a systematic review and meta-analysis.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003614.
    >> Share

  173. STEFANI LD, Trivedi SJ, Ferkh A, Emerson P, et al
    Left atrial mechanics evaluated by two-dimensional strain analysis: alterations in essential hypertension.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003615.
    >> Share

  174. WEI C, Zhang J, Peng S, Liu J, et al
    Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway.
    J Hypertens. 2023 Nov 7. doi: 10.1097/HJH.0000000000003610.
    >> Share

  175. QIU W, Cai A, Li L, Feng Y, et al
    Association of depression trajectories and subsequent hypertension and cardiovascular disease: findings from the CHARLS cohort.
    J Hypertens. 2023 Nov 2. doi: 10.1097/HJH.0000000000003609.
    >> Share


  176. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    J Hypertens. 2023;41:1872.
    >> Share


  177. Prevalence of non-steroidal anti-inflammatory drugs (NSAIDS) use in patients with hypertensive crisis: Erratum.
    J Hypertens. 2023;41:1871.
    >> Share


  178. PS-P12-8: The prevalence of hypertension in factory employees, detected during the periodic examination at the factory: Erratum.
    J Hypertens. 2023;41:1868.
    >> Share

  179. TABARA Y
    Reply to 'Phenotyping sleep hypertension; never forgetting the night'.
    J Hypertens. 2023;41:1867.
    >> Share

  180. CUSPIDI C, Gherbesi E, Tadic M
    Phenotyping masked hypertension: do not forget the night.
    J Hypertens. 2023;41:1865-1866.
    >> Share

  181. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.
    J Hypertens. 2023;41:1864-1865.
    >> Share

  182. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    Reply to 'Examining the impact of E-health management on hypertension'.
    J Hypertens. 2023;41:1864.
    >> Share

  183. FATIMA HE, Lo DF
    Examining the impact of E-health management on hypertension.
    J Hypertens. 2023;41:1863.
    >> Share

  184. CARDOSO AM, Aneli NM, Lammers M, Manica A, et al
    Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling.
    J Hypertens. 2023;41:1745-1752.
    >> Share

  185. SHI M, Liu Y, Wang S, Wang R, et al
    Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke.
    J Hypertens. 2023;41:1730-1737.
    >> Share

  186. SHOKOPLES BG, Berillo O, Comeau K, Chen HY, et al
    P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation.
    J Hypertens. 2023;41:1701-1712.
    >> Share

  187. SULICKA-GRODZICKA J, Guzik TJ
    The ATP connection: a new therapeutic promise of P2X7 targeting in hypertension and vascular injury.
    J Hypertens. 2023;41:1696-1698.
    >> Share

  188. SONG J, Tan M, Wang C, Brown MK, et al
    Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
    J Hypertens. 2023;41:1713-1720.
    >> Share

  189. SCHMIDT-LAUBER C, Alba Schmidt E, Hanzelmann S, Petersen EL, et al
    Increased blood pressure after nonsevere COVID-19.
    J Hypertens. 2023;41:1721-1729.
    >> Share

  190. LEE SH, Lee CJ, Kang Y, Park JM, et al
    A randomized trial of genotype-guided perindopril use.
    J Hypertens. 2023;41:1768-1774.
    >> Share

  191. WIERSINGA JHI, Rhodius-Meester HFM, Wolters FJ, Trappenburg MC, et al
    Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population.
    J Hypertens. 2023;41:1738-1744.
    >> Share


  192. Skin NA+, K+ and water before and after surgical cure of human primary aldosteronism: Erratum.
    J Hypertens. 2023;41:1869.
    >> Share

  193. FENG L, Ye Z, Mo C, Wang J, et al
    Elevated blood pressure accelerates white matter brain aging among late middle-aged women: a Mendelian Randomization study in the UK Biobank.
    J Hypertens. 2023;41:1811-1820.
    >> Share

  194. ZHANG X, Zhou Y, Yang J, Wang Y, et al
    Trend of blood pressure changes among children from 2012 to 2022: findings from student health surveillance in Eastern China.
    J Hypertens. 2023;41:1821-1830.
    >> Share

  195. YOUNIS D, Mosbah A, Zakaria MM, Awadalla A, et al
    Urinary congophilia in pregnancy: a marker of kidney injury rather than preeclampsia.
    J Hypertens. 2023;41:1760-1767.
    >> Share

    October 2023
  196. ZAHNER MR, Brown MC, Chandley MJ
    Inactivation of the paraventricular nucleus attenuates the cardiogenic sympathetic afferent reflex in the spontaneously hypertensive rat.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003542.
    >> Share

  197. GHAZI L, Cohen JB, Townsend RR, Drawz PE, et al
    Orthostatic hypotension, orthostatic hypertension, and ambulatory blood pressure in patients with chronic kidney disease in CRIC.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003604.
    >> Share

  198. MA H, Wang C, Jiang M, Jin K, et al
    Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension.
    J Hypertens. 2023 Oct 23. doi: 10.1097/HJH.0000000000003601.
    >> Share

  199. KASANAGOTTU K, Mukamal KJ, Landon BE
    Predictors of treatment intensification in uncontrolled hypertension.
    J Hypertens. 2023 Oct 20. doi: 10.1097/HJH.0000000000003598.
    >> Share

  200. SASAKI N, Ueno Y, Ozono R, Yoshimura K, et al
    Association of serum uric acid levels with blood pressure and the incidence of hypertension in the middle-aged and elderly populations.
    J Hypertens. 2023 Oct 12. doi: 10.1097/HJH.0000000000003597.
    >> Share

  201. ARAUJO-CASTRO M, Garcia Sanz I, Minguez Ojeda C, Hanzu F, et al
    Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
    J Hypertens. 2023 Oct 11. doi: 10.1097/HJH.0000000000003596.
    >> Share

  202. MANCIA G, Facchetti R, Quarti-Trevano F, Dell'Oro R, et al
    Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003582.
    >> Share

  203. LI M, Qu K, Wang Y, Wang Y, et al
    Associations of hypertensive disorders of pregnancy with cognition, dementia, and brain structure: a Mendelian randomization study.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003593.
    >> Share

  204. PEETERS LEJ, Kappers MHW, Hesselink DA, van der Net JB, et al
    Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003585.
    >> Share

  205. RIJAL A, Adhikari TB, Dhakal S, Maagaard M, et al
    Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003589.
    >> Share

  206. BROSOLO G, Da Porto A, Bulfone L, Vacca A, et al
    Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003590.
    >> Share

  207. BASTA K, Ledwaba-Chapman L, Dodhia H, Ashworth M, et al
    Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021.
    J Hypertens. 2023 Oct 2. doi: 10.1097/HJH.0000000000003584.
    >> Share


  208. A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension: Retraction.
    J Hypertens. 2023;41:1673.
    >> Share

  209. MISCHAK H
    Further comments on 'A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension'.
    J Hypertens. 2023;41:1667.
    >> Share

  210. MISCHAK H
    Comment on 'A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension' by Lin et al.
    J Hypertens. 2023;41:1666.
    >> Share

  211. XIE B, Li L, Lin M, Nanna M, et al
    99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heart.
    J Hypertens. 2023;41:1645-1652.
    >> Share

  212. ABUELAZM M, Saleh O, Albarakat MM, Katamesh B, et al
    The effect of bedtime versus morning dosing of antihypertensive drugs on the cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2023;41:1595-1605.
    >> Share

  213. TOMODA F, Koike T, Nitta A, Kurosaki H, et al
    Urinary levels of cortisol but not catecholamines are associated with those of 8-hydroxy-2'-deoxyguanosine in uncomplicated primary hypertension.
    J Hypertens. 2023;41:1571-1577.
    >> Share

  214. RIVASI G, Fedorowski A
    Harm vs. benefit of antihypertensive treatment in very old and frail people - do not miss the forest for the trees.
    J Hypertens. 2023;41:1551-1553.
    >> Share

  215. AKINTUNDE AA, Mutagaywa R, Manmak M, Oguntade AS, et al
    Task sharing in the management of hypertension: highlights of the African hypertension school for nonphysicians health workers.
    J Hypertens. 2023;41:1544-1550.
    >> Share

  216. ZUO X, Liu L, Liu K, Zhang X, et al
    Proximal aorta dilatation in hypertension.
    J Hypertens. 2023;41:1511-1520.
    >> Share

  217. FONSECA R, Palmer AJ, Picone DS, Cox IA, et al
    Cardiovascular and health cost impacts of cuff blood pressure underestimation and overestimation of invasive aortic systolic blood pressure.
    J Hypertens. 2023;41:1585-1594.
    >> Share

    September 2023
  218. DE LA SIERRA A, Ruilope LM, Martinez-Camblor P, Vinyoles E, et al
    Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.
    J Hypertens. 2023 Sep 27. doi: 10.1097/HJH.0000000000003581.
    >> Share

  219. DUTRA RT, Bensenor IM, Goulart AC, Pereira AC, et al
    Carotid intima-media thickness and incident hypertension: the Brazilian Longitudinal Study of Adult Health.
    J Hypertens. 2023 Sep 19. doi: 10.1097/HJH.0000000000003567.
    >> Share

  220. OHARA H, Takeuchi F, Kato N, Nabika T, et al
    Genotypes of Stim1 and the proximal region on chromosome 1 exert opposite effects on stroke susceptibility in stroke-prone spontaneously hypertensive rat.
    J Hypertens. 2023 Sep 15. doi: 10.1097/HJH.0000000000003566.
    >> Share

  221. RIVASI G, Ceolin L, Turrin G, Tortu' V, et al
    Prevalence and correlates of frailty in older hypertensive outpatients according to different tools: the HYPER-FRAIL pilot study.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003559.
    >> Share

  222. BOS-ROUBOS AG, Wingbermuhle E, Giesen M, Kersseboom R, et al
    Hypertension with hidden causes: the cognitive and behavioral profile of an adult female with chronic stress and 16p11.2 microdeletion.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003565.
    >> Share

  223. SHI Y, Zhou W
    Threshold effect of systemic immune inflammatory index on hypertension in American adults (NHANES 2017-2020).
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003560.
    >> Share

  224. CHARCHAR FJ, Prestes PR, Mills C, Ching SM, et al
    Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003563.
    >> Share

  225. MA G, Li J, Xie J, Li Y, et al
    Pulse pressure and its association with body composition among Chinese men and women without diagnosed hypertension: the China Kadoorie Biobank.
    J Hypertens. 2023 Sep 7. doi: 10.1097/HJH.0000000000003549.
    >> Share

  226. ALNAZER RM, Veldhuizen GP, de Leeuw PW, Kroon AA, et al
    Reply to 'Could we be missing something when calculating the aldosterone-to-renin ratio?'.
    J Hypertens. 2023;41:1500.
    >> Share

  227. KARADENIZ A, Babayigit E, Gorenek B
    Could we be missing something when calculating the aldosterone-to-renin ratio?
    J Hypertens. 2023;41:1499.
    >> Share

  228. KASPER P, Demir M, Steffen HM
    Liver fibrosis scores to predict cardiovascular events in hypertensive patients: old wine in new skins?
    J Hypertens. 2023;41:1498-1499.
    >> Share

  229. PHONANUWONG R, Jannoo S, Chanthanuwat S, Soonthornpun S, et al
    Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism.
    J Hypertens. 2023;41:1493-1497.
    >> Share

  230. BEANEY T, Wang W, Schlaich MP, Schutte AE, et al
    Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign.
    J Hypertens. 2023;41:1446-1455.
    >> Share

  231. RENLUND MA, Jaaskelainen TJ, Kivela ASE, Heinonen ST, et al
    Blood pressure, arterial stiffness, and cardiovascular risk profiles in 8-12-year-old children following preeclampsia (FINNCARE-study).
    J Hypertens. 2023;41:1429-1437.
    >> Share

  232. WANG Y, Liu H, Wang J, Hu X, et al
    The association between brachial-ankle pulse-wave velocity and adverse cardiovascular events in 5719 community participants a prospective cohort study.
    J Hypertens. 2023;41:1411-1419.
    >> Share

  233. ALVES-LOPES R, Lacchini S, Neves KB, Harvey A, et al
    Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells.
    J Hypertens. 2023;41:1389-1400.
    >> Share

  234. TROPEA T, Mavichak W, Evangelinos A, Brennan-Richardson C, et al
    Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy.
    J Hypertens. 2023 Sep 1. doi: 10.1097/HJH.0000000000003532.
    >> Share

    August 2023
  235. BOUDREAUX BD, Romero EK, Diaz KM
    Sedentary behavior and risk of cardiovascular disease and all-cause mortality in United States adults with hypertension.
    J Hypertens. 2023 Aug 22. doi: 10.1097/HJH.0000000000003540.
    >> Share

  236. LIN L, Ren J, Wang C, Mei M, et al
    A set of urinary peptides can predict early renal damage in primary hypertension.
    J Hypertens. 2023 Aug 21. doi: 10.1097/HJH.0000000000003539.
    >> Share

  237. CHEN Y, Ye P, Dong H, Xu X, et al
    Clinical characteristics of pediatric hypertension: a multicenter study in China.
    J Hypertens. 2023 Aug 15. doi: 10.1097/HJH.0000000000003533.
    >> Share

  238. GRASSI G
    Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices.
    J Hypertens. 2023 Aug 15. doi: 10.1097/HJH.0000000000003538.
    >> Share

  239. KIM JH, Joo HJ, Chung SH, Yum Y, et al
    Safety and cardiovascular effectiveness of olmesartan in combination therapy for advanced hypertension: an electronic health record-based cohort study.
    J Hypertens. 2023 Aug 4. doi: 10.1097/HJH.0000000000003509.
    >> Share

  240. RAN S, Wu Y, Liu B
    Associations of appendicular lean mass and walking pace with hypertension: a two-sample Mendelian randomization study.
    J Hypertens. 2023;41:1347-1348.
    >> Share

  241. SCHUTTE AE, Tan I, Gnanenthiran SR, Chan J, et al
    Reply to 'Inadequate study designs for the evaluation of blood pressure monitoring devices and their potential misleading conclusions'.
    J Hypertens. 2023;41:1349-1350.
    >> Share

  242. ALMEIDA TP, Perruchoud D, Shah J, Sola J, et al
    Inadequate study designs for the evaluation of blood pressure monitoring devices and their potential misleading conclusions.
    J Hypertens. 2023;41:1348-1349.
    >> Share

  243. PIANI F, Agnoletti D, Baracchi A, Scarduelli S, et al
    Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes.
    J Hypertens. 2023;41:1333-1338.
    >> Share

  244. LIU X, Rosenberg C, Reaso JN, Lee AM, et al
    Skin sympathetic nerve activity and nocturnal blood pressure nondipping in patients with postural orthostatic tachycardia syndrome.
    J Hypertens. 2023;41:1290-1297.
    >> Share

  245. LIULU X, Hungerford S
    Evaluation of contemporary methods to determine vascular impedance.
    J Hypertens. 2023;41:1221-1230.
    >> Share

    July 2023
  246. WOODE ME, Wong K, Reid CM, Stowasser M, et al
    Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis.
    J Hypertens. 2023 Jul 19. doi: 10.1097/HJH.0000000000003513.
    >> Share

  247. MARQUES SM, Melo MR, Zoccal DB, Menani JV, et al
    Acute inhibition of nicotinamide adenine dinucleotide phosphate oxidase in the commissural nucleus of the solitary tract reduces arterial pressure and renal sympathetic nerve activity in renovascular hypertension.
    J Hypertens. 2023 Jul 19. doi: 10.1097/HJH.0000000000003516.
    >> Share

  248. WILSON AJ, Sands GB, Wang VY, Pontre B, et al
    Quinapril treatment curtails decline of global longitudinal strain and mechanical function in hypertensive rats.
    J Hypertens. 2023 Jul 18. doi: 10.1097/HJH.0000000000003512.
    >> Share

  249. ZHU M, An D, Zhang J, Tang X, et al
    Genome-wide analysis of DNA methylation and its relationship with serum homocysteine levels in patients with hypertension.
    J Hypertens. 2023 Jul 14. doi: 10.1097/HJH.0000000000003515.
    >> Share

  250. KOSITANURIT W, Korakot M, Burana C, Varachotisate P, et al
    Acute effect of various dosages of sugar ingestion on vascular function in offspring of hypertensive and normotensive parents.
    J Hypertens. 2023 Jul 7. doi: 10.1097/HJH.0000000000003500.
    >> Share

  251. SALMAN IM
    Functional symmetry of the aortic baroreflex in female spontaneously hypertensive rats.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003493.
    >> Share

  252. WATZ MES, Tivesten A, Ottarsdottir K, Li Y, et al
    Sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003506.
    >> Share

  253. REA F, Morabito G, Savare L, Pathak A, et al
    Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003497.
    >> Share

  254. TOMAZELLI CA, Ishikawa FM, Couto GK, Parente JM, et al
    Small artery remodeling and stiffening in deoxycorticosterone acetate-salt hypertensive rats involves the interaction between endogenous ouabain/Na+K+-ATPase/cSrc signaling.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003502.
    >> Share

  255. ARDISSINO M, Reddy RK, Slob EAW, Griffiths J, et al
    Maternal hypertensive traits and adverse outcome in pregnancy: a Mendelian randomization study.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003486.
    >> Share

  256. SHANTSILA E, Lip GYH, Shantsila A, Kurpas D, et al
    Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003495.
    >> Share

  257. BATUBO NP, Moore JB, Zulyniak MA
    Dietary factors and hypertension risk in West Africa: a systematic review and meta-analysis of observational studies.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003499.
    >> Share

  258. BUTALA S, Galido PV, Chakerian M, Woo BKP, et al
    Community-based interventions in hypertension management and its implications for the future of primary care.
    J Hypertens. 2023;41:1216-1217.
    >> Share

  259. LOVGREN T
    Reply to 'Critical commentary on labetalol and nifedipine use in postpartum hypertension management'.
    J Hypertens. 2023;41:1215-1216.
    >> Share

  260. WASIF U, Al-Shehab U, Lo DF
    Critical commentary on labetalol and nifedipine use in postpartum hypertension management.
    J Hypertens. 2023;41:1215.
    >> Share

  261. GOSSE P, Boulestreau R, Doublet J, Laurent S, et al
    How to measure arterial stiffness independently of blood pressure: the QKD method.
    J Hypertens. 2023;41:1168-1174.
    >> Share

  262. SCHNEIDER VM, Domingues LB, Umpierre D, Tanaka H, et al
    Exercise characteristics and blood pressure reduction after combined aerobic and resistance training: a systematic review with meta-analysis and meta-regression.
    J Hypertens. 2023;41:1068-1076.
    >> Share

  263. YU YL, Moliterno P, An DW, Raaijmakers A, et al
    Blood pressure and cardiovascular risk in relation to birth weight and urinary sodium: an individual-participant meta-analysis of European family-based population studies.
    J Hypertens. 2023;41:1175-1183.
    >> Share

  264. MORICONI D, Mengozzi A, Duranti E, Cappelli F, et al
    The renal resistive index is associated with microvascular remodeling in patients with severe obesity.
    J Hypertens. 2023;41:1092-1099.
    >> Share

    June 2023
  265. LI Y, Niu Y, Liu M, Lan X, et al
    First-trimester serum antiphosphatidylserine antibodies serve as candidate biomarkers for predicting pregnancy-induced hypertension.
    J Hypertens. 2023 Jun 27. doi: 10.1097/HJH.0000000000003498.
    >> Share

  266. KOCIANOVA E, Vaclavik J
    A practical approach to assessment of non-adherence to antihypertensive treatment.
    J Hypertens. 2023 Jun 21. doi: 10.1097/HJH.0000000000003492.
    >> Share

  267. MANCIA CHAIRPERSON G, Kreutz Co-Chair R, Brunstrom M, Burnier M, et al
    2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypert
    J Hypertens. 2023 Jun 21. doi: 10.1097/HJH.0000000000003480.
    >> Share

  268. STERGIOU GS, Parati G, Kollias A, Schutte AE, et al
    Requirements for design and function of blood pressure measuring devices used for the management of hypertension: Consensus Statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular variability and
    J Hypertens. 2023 Jun 12. doi: 10.1097/HJH.0000000000003482.
    >> Share

  269. STERGIOU GS, Avolio AP, Palatini P, Kyriakoulis KG, et al
    European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2023 Jun 12. doi: 10.1097/HJH.0000000000003483.
    >> Share

  270. JESUS RLC, Araujo FA, Alves QL, Dourado KC, et al
    Targeting temperature-sensitive transient receptor potential channels in hypertension: far beyond the perception of hot and cold.
    J Hypertens. 2023 Jun 12. doi: 10.1097/HJH.0000000000003487.
    >> Share

  271. TAHERI S, Eshgabadi A, Fatuyi M, Rahima K, et al
    Eight-and-a-half syndrome in a patient with hypertensive emergencies.
    J Hypertens. 2023 Jun 9. doi: 10.1097/HJH.0000000000003468.
    >> Share

  272. KOHAGURA K, Satoh A, Kochi M, Nakamura T, et al
    Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial.
    J Hypertens. 2023 Jun 9. doi: 10.1097/HJH.0000000000003484.
    >> Share

  273. CHOY KW, Liwayan R
    Screening for secondary hypertension: the 'SH-Screening' Shiny app.
    J Hypertens. 2023;41:1053.
    >> Share

  274. AL-SHEHAB U, Lo DF
    Association of antihypertensive medications with the risk of dementia.
    J Hypertens. 2023;41:1051-1052.
    >> Share

  275. NILSSON PM
    Birth weight and hypertension: nature or nurture?
    J Hypertens. 2023;41:909-911.
    >> Share

  276. KYAW T, Drummond G, Bobik A
    Interferon regulatory factor 4 a master regulator of hypertensive kidney fibrosis and inflammation?
    J Hypertens. 2023;41:906-908.
    >> Share

  277. LOPEZ-SUBLET M, Merkling T, Girerd N, Xhaard C, et al
    Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study).
    J Hypertens. 2023;41:1040-1050.
    >> Share

  278. TAN I, Gnanenthiran SR, Chan J, Kyriakoulis KG, et al
    Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes.
    J Hypertens. 2023;41:1003-1010.
    >> Share

  279. PAGEAU LM, Ng TJ, Ling J, Given BA, et al
    Associations between hair cortisol and blood pressure: a systematic review and meta-analysis.
    J Hypertens. 2023;41:875-887.
    >> Share

  280. YOSHIKAWA T, Obayashi K, Miyata K, Jimura H, et al
    Circadian blood pressure variability and asymmetric dimethylarginine in patients with glaucoma: cross-sectional study of The LIGHT cohort.
    J Hypertens. 2023;41:1018-1023.
    >> Share

  281. FACONTI L, Farukh B, McNally RJ, Brett S, et al
    Impaired beta 2 -adrenergic endothelium-dependent vasodilation in patients previously hospitalized with coronavirus disease 2019.
    J Hypertens. 2023;41:951-957.
    >> Share

  282. ROMBERGER NT, Stock JM, Patik JC, McMillan RK, et al
    Inverse salt sensitivity in normotensive adults: role of demographic factors.
    J Hypertens. 2023;41:934-940.
    >> Share

  283. GOTZINGER F, Wilke T, Hardtstock F, Krieger J, et al
    Association of hydrochlorothiazide treatment compared with alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study.
    J Hypertens. 2023;41:926-933.
    >> Share

  284. DUDOIGNON B, Bokov P, Couque N, Denjoy I, et al
    Neurogenic hypertension characterizes children with congenital central hypoventilation syndrome and is aggravated by alveolar hypoventilation during sleep.
    J Hypertens. 2023 Jun 1. doi: 10.1097/HJH.0000000000003475.
    >> Share

    May 2023
  285. CHENG W, Xu W, Luan S, Wen G, et al
    Predictive value of estimated pulse wave velocity with all-cause and cause-specific mortality in the hypertensive population: the National Health and Nutrition Examination Surveys 1999-2014.
    J Hypertens. 2023 May 24. doi: 10.1097/HJH.0000000000003469.
    >> Share

  286. TONG L, Chen G, Liu T, Wang L, et al
    IFN-gamma deficiency in the rostral ventrolateral medulla contributes to stress-induced hypertension by impairing microglial synaptic engulfment.
    J Hypertens. 2023 May 24. doi: 10.1097/HJH.0000000000003470.
    >> Share

  287. LIN L, Wang C, Ren J, Mei M, et al
    A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension.
    J Hypertens. 2023 May 17. doi: 10.1097/HJH.0000000000003467.
    >> Share

  288. TABARA Y, Matsumoto T, Murase K, Setoh K, et al
    Sleep-related factors associated with masked hypertension: the Nagahama study.
    J Hypertens. 2023 May 16. doi: 10.1097/HJH.0000000000003466.
    >> Share

  289. MBUTIWI FIN, Sylvestre MP
    Accounting for antihypertensive medication in Mendelian randomization studies of blood pressure: methodological considerations in the Canadian Longitudinal Study on Aging.
    J Hypertens. 2023 May 15. doi: 10.1097/HJH.0000000000003464.
    >> Share

  290. DOROBANTU M, Cojocaru C, Stanciulescu L, Pop C, et al
    Ups and downs of conducting a national representative survey on hypertension during pandemic time: main results of SEPHAR IV.
    J Hypertens. 2023 May 10. doi: 10.1097/HJH.0000000000003461.
    >> Share

  291. PEETERS LEJ, Hesselink DA, Lafeber M, Severs D, et al
    Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant.
    J Hypertens. 2023 May 8. doi: 10.1097/HJH.0000000000003459.
    >> Share


  292. Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage: Erratum.
    J Hypertens. 2023;41:873.
    >> Share

  293. OMBONI S
    Reply to 'Extreme dipping: is the nocturnal blood pressure fall modulated by age?'.
    J Hypertens. 2023;41:868-869.
    >> Share

  294. PALATINI P
    Extreme dipping: is the nocturnal blood pressure fall modulated by age?
    J Hypertens. 2023;41:867.
    >> Share

  295. ALCOCER L
    Casual and inaccurate measurements of a continuous fluctuating variable: the original sin of the concept of arterial hypertension?
    J Hypertens. 2023;41:709-710.
    >> Share

  296. NILLES EK, Champon X, Mulder H, Shaw KM, et al
    Seasonal variation in blood pressure control across US health systems.
    J Hypertens. 2023;41:751-758.
    >> Share

  297. ZHONG X, Li Z, Xu Q, Peng H, et al
    Short-chain acyl-CoA dehydrogenase is a potential target for the treatment of vascular remodelling.
    J Hypertens. 2023;41:775-793.
    >> Share

  298. STERGIOU GS, Menti A, Asayama K, De La Sierra A, et al
    Accuracy of automated cuff blood pressure monitors in special populations: International Organization for Standardization (ISO) Task Group report and call for research.
    J Hypertens. 2023;41:811-818.
    >> Share

  299. HEYDARPOUR M, Parksook WW, Hopkins PN, Pojoga LH, et al
    A candidate locus in the renalase gene and susceptibility to blood pressure responses to the dietary salt.
    J Hypertens. 2023;41:723-732.
    >> Share

    April 2023
  300. SALMAN IM, Ameer OZ, McMurray S, Hassan SF, et al
    Differential central integration of left versus right baroreceptor afferent input in spontaneously hypertensive rats.
    J Hypertens. 2023 Apr 20. doi: 10.1097/HJH.0000000000003448.
    >> Share

  301. CHANG CL, Cai Z, Hsu SYT
    Stable adrenomedullin analog mitigates placental ischemia-induced hypertension and fetal growth restriction in rats.
    J Hypertens. 2023 Apr 18. doi: 10.1097/HJH.0000000000003440.
    >> Share

  302. YAMADA M, Wachsmuth J, Sambharia M, Griffin BR, et al
    The prevalence and treatment of hypertension in Veterans Health Administration, assessing the impact of the updated clinical guidelines.
    J Hypertens. 2023 Apr 18. doi: 10.1097/HJH.0000000000003424.
    >> Share

  303. CHEN J, Pei Y, Wang Q, Li C, et al
    Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension.
    J Hypertens. 2023 Apr 18. doi: 10.1097/HJH.0000000000003430.
    >> Share

  304. HU B, He X, Li F, Sun Y, et al
    Childhood obesity and hypertension in pregnancy: a two-sample Mendelian randomization analysis.
    J Hypertens. 2023 Apr 7. doi: 10.1097/HJH.0000000000003442.
    >> Share

  305. MENDOZA-QUISPE D, Chambergo-Michilot D, Moscoso-Porras M, Bernabe-Ortiz A, et al
    Hypertension prevalence by degrees of urbanization and altitude in Peru: pooled analysis of 186 906 participants.
    J Hypertens. 2023 Apr 7. doi: 10.1097/HJH.0000000000003444.
    >> Share

  306. OU YH, Ong J, Thant AT, Koo CY, et al
    The Belun sleep platform to diagnose obstructive sleep apnea in patients with hypertension and high cardiovascular risk.
    J Hypertens. 2023 Apr 7. doi: 10.1097/HJH.0000000000003426.
    >> Share

  307. CHAKRABORTY S, Lulla A, Cheng X, Yeo JY, et al
    Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites.
    J Hypertens. 2023 Apr 6. doi: 10.1097/HJH.0000000000003423.
    >> Share

  308. KERKHOFS D, Helgers R, Hermes D, Steinbusch HPJ, et al
    Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice.
    J Hypertens. 2023 Apr 6. doi: 10.1097/HJH.0000000000003445.
    >> Share

  309. TANNER RM, Chaudary N, Colantonio LD, Merriman TR, et al
    Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    J Hypertens. 2023 Apr 5. doi: 10.1097/HJH.0000000000003425.
    >> Share

  310. GAO ZX, Wei QC, Shu TT, Li ST, et al
    Kir4.1 deletion prevents salt-sensitive hypertension in early streptozotocin-induced diabetic mice via Na+-Cl- cotransporter in the distal convoluted tubule.
    J Hypertens. 2023 Apr 5. doi: 10.1097/HJH.0000000000003419.
    >> Share

  311. AF GEIJERSTAM P, Engvall J, Ostgren CJ, Radholm K, et al
    Masked hypertension in a middle-aged population and its relation to manifestations of vascular disease.
    J Hypertens. 2023 Apr 4. doi: 10.1097/HJH.0000000000003431.
    >> Share

  312. MARTINS VM, Ziegelmann PK, Ferrari F, Bottino LG, et al
    Thiazide diuretics alone or combined with potassium-sparing diuretics to treat hypertension: a systematic review and network meta-analysis of randomized controlled trials.
    J Hypertens. 2023 Apr 4. doi: 10.1097/HJH.0000000000003436.
    >> Share

  313. WOODS AP, Feeney T, Papageorge MV, de Geus SWL, et al
    Addressing diagnostic inertia following incidental adrenal mass discovery in patients with hypertension.
    J Hypertens. 2023;41:680-682.
    >> Share

  314. GALLAGHER BD, Windish DM
    State of ambulatory hypertension education in U.S. internal medicine residency programs: a needs assessment survey.
    J Hypertens. 2023;41:678-679.
    >> Share

  315. CARNAGARIN R, Nolde JM, Yang J, Marques FZ, et al
    Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns.
    J Hypertens. 2023;41:632-637.
    >> Share

    March 2023
  316. GALVAO L, Povoa TIR, Jardim PCV, Lima AL, et al
    Acute effects of high-intensity resistance training on central blood pressure parameters of elderly hypertensive women: a crossover clinical trial.
    J Hypertens. 2023 Mar 30. doi: 10.1097/HJH.0000000000003355.
    >> Share

  317. LACY PS, Jedrzejewski D, McFarlane E, Williams B, et al
    Blood pressure measurement modalities and indexed left ventricular mass in men with low-risk hypertension confirmed by ambulatory monitoring.
    J Hypertens. 2023 Mar 10. doi: 10.1097/HJH.0000000000003415.
    >> Share

  318. LI D, Zhang S, Cao F, Han J, et al
    The sustainable antihypertensive and target organ damage protective effect of transcranial focused ultrasound stimulation in spontaneously hypertensive rats.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003407.
    >> Share

  319. XUE CC, Li C, Hu JF, Wei CC, et al
    Retinal vessel caliber and tortuosity and prediction of 5-year incidence of hypertension.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003406.
    >> Share

  320. UKOHA-KALU BO, Adibe MO, Ukwe CV
    A qualitative study of patients' and carers' perspectives on factors influencing access to hypertension care and compliance with treatment in Nigeria.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003409.
    >> Share

  321. GOULAS I, Evripidou K, Doundoulakis I, Kollios K, et al
    Prevalence of masked hypertension and its association with left ventricular hypertrophy in children and young adults with chronic kidney disease: a systematic review and meta-analysis.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003402.
    >> Share

  322. XIONG S, Yin S, Deng W, Zhao Y, et al
    Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003394.
    >> Share

  323. GAO Y, Liu B, Guo X, Nie J, et al
    Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003401.
    >> Share

  324. WU S, Tian X, Chen S, Zhang Y, et al
    Arterial stiffness and blood pressure in treated hypertension: a longitudinal study.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003400.
    >> Share

  325. KUMAR SM, Anandraj J, Sivanatham P, Essakky S, et al
    Control status of hypertension in India: systematic review and meta-analysis.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003381.
    >> Share

  326. STERGIOU G, MacDonald T, Young R, Kyriakoulis KG, et al
    Reply to 'Evening or morning dosing of antihypertensive medications: valid epidemiological findings for consensus statement'.
    J Hypertens. 2023;41:525-526.
    >> Share

  327. KAWADA T
    Evening or morning dosing of antihypertensive medications: valid epidemiological findings for consensus statement.
    J Hypertens. 2023;41:525.
    >> Share

  328. NURKKALA J, Kauko A, FinnGen, Laivuori H, et al
    Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy.
    J Hypertens. 2023;41:380-387.
    >> Share

  329. MEDEIROS BM, Da Silva TLN, Bloch KV, Kuschnir MCC, et al
    Adolescent blood pressure classification curves and cardiometabolic risk factors: a comparison of the Brazilian and American references.
    J Hypertens. 2023;41:420-428.
    >> Share

  330. AVILA-GANDIA V, Ramos-Campo DJ, Garcia-Sanchez E, Luque-Rubia AJ, et al
    Training, detraining and retraining effects of moderate vs. high intensity exercise training programme on cardiovascular risk factors.
    J Hypertens. 2023;41:411-419.
    >> Share

  331. ZEIJEN VJM, Hirsch A, Betjes MGH, Daemen J, et al
    Unilateral renal atrophy 4 years after renal sympathetic denervation: a case report.
    J Hypertens. 2023;41:516-519.
    >> Share

  332. KOBAYASHI A, Fujihara K, Yamada MH, Sato T, et al
    Combined effects of blood pressure and glycemic status on risk of heart failure: a population-based study.
    J Hypertens. 2023;41:470-475.
    >> Share

  333. KANTAUSKAITE M, Furst G, Minko P, Antoch G, et al
    How acute renal failure led to the diagnosis of aortic coarctation.
    J Hypertens. 2023;41:520-524.
    >> Share

  334. ZEIJEN VJM, Feyz L, Kardys I, Geleijnse ML, et al
    Association between renal sympathetic denervation and arterial stiffness: the ASORAS study.
    J Hypertens. 2023;41:476-485.
    >> Share

  335. CHALMERS J, Mourad JJ, Brzozowska-Villatte R, De Champvallins M, et al
    Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials.
    J Hypertens. 2023;41:508-515.
    >> Share

    February 2023
  336. PARATI G, Bilo G, Kollias A, Pengo M, et al
    Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper *.
    J Hypertens. 2023 Feb 16. doi: 10.1097/HJH.0000000000003363.
    >> Share

  337. PARISE BK, Santos RB, Mesas AE, Silva WA, et al
    Sleep irregularity and the association with hypertension and blood pressure levels: the ELSA-Brasil study.
    J Hypertens. 2023 Feb 13. doi: 10.1097/HJH.0000000000003392.
    >> Share

  338. CARDOSO CRL, Leite NC, Salles GF
    Relative prognostic importance of aortic and brachial blood pressures for cardiovascular and mortality outcomes in patients with resistant hypertension and diabetes: a two cohorts prospective study.
    J Hypertens. 2023 Feb 2. doi: 10.1097/HJH.0000000000003387.
    >> Share

  339. KAWADA T
    Cardiovascular disease risk in patients with type 2 diabetes and hypertension.
    J Hypertens. 2023;41:365.
    >> Share

  340. CUSPIDI C, Gherbesi E, Faggiano A, Sala C, et al
    Unmasking left ventricular systolic dysfunction in masked hypertension: looking at myocardial strain. A review and meta-analysis.
    J Hypertens. 2023;41:344-350.
    >> Share

  341. HOLWERDA SW, Gangwish ME, Luehrs RE, Nuckols VR, et al
    Concomitantly higher resting arterial blood pressure and transduction of sympathetic neural activity in human obesity without hypertension.
    J Hypertens. 2023;41:326-335.
    >> Share

  342. REN R, Zhang Y, Yang L, Shi Y, et al
    Sleep fragmentation during rapid eye movement sleep and hypertension in obstructive sleep apnea.
    J Hypertens. 2023;41:310-315.
    >> Share

  343. GHAZI L, Li F, Simonov M, Yamamoto Y, et al
    Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage.
    J Hypertens. 2023;41:288-294.
    >> Share

  344. BO Y, Yu T, Guo C, Chang LY, et al
    Isolated systolic or diastolic hypertension and mortality risk in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline: a longitudinal cohort study.
    J Hypertens. 2023;41:271-279.
    >> Share

  345. WANG FZ, Qian P, Liu MY, Ding L, et al
    Adrenomedullin in paraventricular nucleus attenuates adipose afferent reflex and sympathoexcitation via receptors mediated nitric oxide-gamma-aminobutyric acid A type receptor pathway in rats with obesity-related hypertension.
    J Hypertens. 2023;41:233-245.
    >> Share

  346. VAN TWIST DJL, Kietselaer BLJH
    Intravenous antihypertensive drugs: a double-edged sword?
    J Hypertens. 2023;41:220-222.
    >> Share

  347. LI Y, Haseler E, McNally R, Sinha MD, et al
    A meta-analysis of the haemodynamics of primary hypertension in children and adults.
    J Hypertens. 2023;41:212-219.
    >> Share

  348. JONES L, Blair J, Hawcutt DB, Lip GYH, et al
    Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.
    J Hypertens. 2023;41:203-211.
    >> Share

  349. BRGULJAN-HITIJ J, McNally R, Sinigoj P, Hornstrup BG, et al
    ESH Summer School 2022: great experience for participants and an important achievement for ESH organization.
    J Hypertens. 2023;41:365-368.
    >> Share

  350. KAKALETSIS N, Ntaios G, Milionis H, Protogerou AD, et al
    Time of blood pressure in target range in acute ischemic stroke.
    J Hypertens. 2023;41:303-309.
    >> Share

  351. PEWOWARUK RJ, Hein AJ, Hansen KM, Barnes JN, et al
    Exercise increases arterial stiffness independent of blood pressure in older Veterans.
    J Hypertens. 2023;41:316-325.
    >> Share

  352. OMBONI S, Ballatore T, Rizzi F, Tomassini F, et al
    Age-related patterns of ambulatory blood pressure in a large cohort of individuals referred to Italian community pharmacies: results from the templar project.
    J Hypertens. 2023;41:336-343.
    >> Share

  353. ZHOU TL, Reulen JPH, Van Der Staaij H, Stehouwer CDA, et al
    Cardiovagal baroreflex sensitivity, blood pressure and blood pressure variability - the Maastricht study.
    J Hypertens. 2023;41:254-261.
    >> Share

  354. CAMPBELL NRC, Whelton PP, Orias M, Cobb LL, et al
    It is strongly recommended to not conduct, fund, or publish research studies that use spot urine samples with estimating equations to assess individuals' sodium (salt) intake in association with health outcomes: a policy statement of the World Hyperte
    J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003385.
    >> Share

  355. SUN Y, Guo Y, Xu H, Zhao J, et al
    The relationship between arginine vasopressin gene polymorphisms and plasma copeptin and hypertensive disorders of pregnancy: a nested case-control study.
    J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003376.
    >> Share

  356. KANG YY, Chen Y, Wu QH, Dong H, et al
    Prevalence and clinical characteristics of renovascular hypertension associated with fibromuscular dysplasia in China.
    J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003382.
    >> Share

    January 2023
  357. ALNAZER RM, Veldhuizen GP, de Leeuw PW, Kroon AA, et al
    The effect of age, sex and BMI on the aldosterone-to-renin ratio in essential hypertensive individuals.
    J Hypertens. 2023 Jan 31. doi: 10.1097/HJH.0000000000003377.
    >> Share

  358. REN Y, Shi J, Liu S, Zhu W, et al
    Transcription factor AP-2 gamma/Kruppel-like factor 10 axis is involved in miR-3656-related dysfunction of endothelial cells in hypertension.
    J Hypertens. 2023 Jan 26. doi: 10.1097/HJH.0000000000003359.
    >> Share

  359. HIRAI T, Ueda S, Ogura T, Katayama K, et al
    Hyperkalemia by eplerenone or esaxerenone in the presence or absence of clarithromycin in hypertensive patients: a retrospective observational cohort study.
    J Hypertens. 2023 Jan 20. doi: 10.1097/HJH.0000000000003372.
    >> Share

  360. PEWOWARUK RJ, Colebank MJ, Spronck B, Korcarz CE, et al
    Biomechanics models predict increasing smooth muscle tone as a novel therapeutic target for central arterial dysfunction in hypertension.
    J Hypertens. 2023 Jan 18. doi: 10.1097/HJH.0000000000003370.
    >> Share

  361. BAWAND R, Ghiasian M, Khazaei M, Samadyan M, et al
    Effects of blood pressure unawareness and poor adherence to antihypertensive drugs on outcomes of cerebrovascular accidents among patients with their first-ever stroke.
    J Hypertens. 2023 Jan 13. doi: 10.1097/HJH.0000000000003358.
    >> Share

  362. BOULESTREAU R, Lorthioir A, Persu A, Sarafidis P, et al
    Revisiting malignant hypertension: rationale and design of the 'HAMA cohort', on behalf of the ESH working group 'hypertension and the kidney'.
    J Hypertens. 2023 Jan 10. doi: 10.1097/HJH.0000000000003357.
    >> Share

  363. TAKASE M, Yamada M, Nakamura T, Nakaya N, et al
    Association between lung function and hypertension and home hypertension in a Japanese population: the Tohoku Medical Megabank Community-Based Cohort Study.
    J Hypertens. 2023 Jan 4. doi: 10.1097/HJH.0000000000003356.
    >> Share


  364. Dynamic of bedside ultrasound venous and pulmonary congestion assessment in patients with arterial hypertension and decompensated heart failure: Erratum.
    J Hypertens. 2023;41:200.
    >> Share

  365. CASIGLIA E, Tikhonoff V, Virdis A, Grassi G, et al
    Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values.
    J Hypertens. 2023;41:180-186.
    >> Share

  366. BOTHE TL, Bilo G, Parati G, Haberl R, et al
    Impact of oscillometric measurement artefacts in ambulatory blood pressure monitoring on estimates of average blood pressure and of its variability: a pilot study.
    J Hypertens. 2023;41:140-149.
    >> Share

  367. WALLE-HANSEN MM, Berge T, Vigen T, Myrstad M, et al
    Systolic blood pressure at age 40 and cognitive function 25 years later: the Akershus Cardiac Examination (ACE) 1950 Study.
    J Hypertens. 2023;41:132-139.
    >> Share

  368. PAPADOPOULOU SL, Gkaliagkousi E, Dipla K, Koletsos N, et al
    Relationship of 24-h ambulatory blood pressure variability with micro and macrovascular parameters and hypertension status.
    J Hypertens. 2023;41:74-82.
    >> Share

  369. RUS RR, Pac M, Obrycki L, Sagsak E, et al
    Systolic and diastolic left ventricular function in children with primary hypertension: a systematic review and meta-analysis.
    J Hypertens. 2023;41:51-62.
    >> Share

  370. MALHAME I, Dong S, Syeda A, Ashraf R, et al
    The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
    J Hypertens. 2023;41:17-26.
    >> Share

  371. OBRYCKI L, Sarnecki J, Pac M, Derezinski T, et al
    Accelerated vascular age in adolescents with primary hypertension.
    J Hypertens. 2023;41:171-179.
    >> Share

  372. KARELIUS S, Vahtera J, Suorsa K, Heinonen OJ, et al
    Changes in ambulatory blood pressure during the transition to retirement.
    J Hypertens. 2023;41:187-193.
    >> Share

    December 2022
  373. ROSSI GP, Barton M, Dhaun N, Rizzoni D, et al
    Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors.
    J Hypertens. 2022 Dec 23. doi: 10.1097/HJH.0000000000003314.
    >> Share

  374. SCHRADER B, Conradi C, Luders S, Vaske B, et al
    Health football beats them all: subgroup analysis of the 3F (Fit&Fun with Football) study on white coat hypertension, sustained hypertension, dippers, nondippers, and on pharmacologically un(treated) arterial hypertension.
    J Hypertens. 2022 Dec 19. doi: 10.1097/HJH.0000000000003360.
    >> Share

  375. NTINERI A, Theodosiadi A, Menti A, Kyriakoulis KG, et al
    A novel professional automated auscultatory blood pressure monitor with visual display of Korotkoff sounds: InBody BPBIO480KV validation according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/Inter
    J Hypertens. 2022 Dec 15. doi: 10.1097/HJH.0000000000003341.
    >> Share

  376. LOVGREN T, Connealy B, Yao R, D Dahlke J, et al
    Postpartum medical management of hypertension and risk of readmission for hypertensive complications.
    J Hypertens. 2022 Dec 13. doi: 10.1097/HJH.0000000000003340.
    >> Share

  377. CHOI M, Hwang JR, Sung JH, Byun N, et al
    Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nomega-nitro-l-arginine methyl ester-induced preeclampsia rat model.
    J Hypertens. 2022;40:2459-2468.
    >> Share

  378. LU SY, Hong WZ, Tsai BC, Chang YC, et al
    Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway.
    J Hypertens. 2022;40:2502-2512.
    >> Share

  379. ALI M, Hussein Z, Marshall JM
    Young South Asian women in the United Kingdom show evidence of blunted endothelium-dependent dilatation: implications for future cardiovascular disease.
    J Hypertens. 2022;40:2438-2448.
    >> Share

  380. O'DRISCOLL JM, Edwards JJ, Coleman DA, Taylor KA, et al
    One year of isometric exercise training for blood pressure management in men: a prospective randomized controlled study.
    J Hypertens. 2022;40:2406-2412.
    >> Share

    November 2022
  381. SCHROEVERS JL, Eggink E, Hoevenaar-Blom MP, Van Dalen JW, et al
    Antihypertensive medication classes and the risk of dementia over a decade of follow-up.
    J Hypertens. 2022 Nov 18. pii: 00004872-990000000-00141.
    >> Share

  382. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    PERson-centredness in Hypertension management using Information Technology: a randomized controlled trial in primary care.
    J Hypertens. 2022 Nov 18. pii: 00004872-990000000-00139.
    >> Share


  383. Renal denervation in the antihypertensive arsenal - knowns and known unknowns: Erratum.
    J Hypertens. 2022;40:2322.
    >> Share

  384. MICHAEL N, Sadananthan SA, Yuan WL, Ong YY, et al
    Associations of maternal and foetoplacental factors with prehypertension/hypertension in early childhood.
    J Hypertens. 2022;40:2171-2179.
    >> Share

  385. GNANENTHIRAN SR, Liu H, Tan I, Chan J, et al
    Cuffless blood pressure devices: the gap between patient acceptability and need for validation.
    J Hypertens. 2022;40:2317-2319.
    >> Share

  386. JONES ESW, Lee HY, Khan N, Charchar FJ, et al
    Reduction of salt intake: time for more action.
    J Hypertens. 2022;40:2130-2132.
    >> Share

  387. NOLDE JM, Hillis GS, Atkins E, Von Huben A, et al
    Impact of various night-time period definitions on nocturnal ambulatory blood pressure.
    J Hypertens. 2022;40:2271-2279.
    >> Share

  388. LUGO-GAVIDIA LM, Burger D, Nolde JM, Carnagarin R, et al
    Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes.
    J Hypertens. 2022;40:2210-2218.
    >> Share

  389. GAVISH B, Bursztyn M, Thijs L, Wei DM, et al
    Predictive power of 24-h ambulatory pulse pressure and its components for mortality and cardiovascular outcomes in 11 848 participants recruited from 13 populations.
    J Hypertens. 2022;40:2245-2255.
    >> Share

  390. EDWARDS JJ, Wiles J, O'Driscoll J
    Mechanisms for blood pressure reduction following isometric exercise training: a systematic review and meta-analysis.
    J Hypertens. 2022;40:2299-2306.
    >> Share

  391. BOUWMEESTER TA, van de Velde L, Galenkamp H, Postema PG, et al
    Association between the reflection magnitude and blood pressure in a multiethnic cohort: the Healthy Life in an Urban Setting study.
    J Hypertens. 2022;40:2263-2270.
    >> Share

    October 2022
  392. HORNE CE, Stayt LC, Schutz S, Smith CM, et al
    Symptom experiences in hypertension: a mixed methods systematic review.
    J Hypertens. 2022 Oct 17. pii: 00004872-990000000-00129.
    >> Share

  393. HELLEPUTTE S, Spronck B, Sharman JE, Van Bortel L, et al
    Central blood pressure estimation in type 1 diabetes: impact and implications of peripheral calibration method.
    J Hypertens. 2022 Oct 10. pii: 00004872-990000000-00126.
    >> Share

  394. WOLDSTAD C, Rusinek H, Sweeney E, Butler T, et al
    Quadratic relationship between systolic blood pressure and white matter lesions in individuals with hypertension.
    J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00123.
    >> Share

  395. MIDDELDORP ME, Ariyaratnam JP, Kamsani SH, Albert CM, et al
    Hypertension and atrial fibrillation.
    J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00124.
    >> Share

  396. KALA P, Gawrys O, Miklovic M, Vanourkova Z, et al
    Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
    J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00121.
    >> Share

  397. KEEHN L, Hall WL, Berry SE, Sanders TAB, et al
    Reproducibility of sequential ambulatory blood pressure and pulse wave velocity measurements in normotensive and hypertensive individuals.
    J Hypertens. 2022 Oct 3. pii: 00004872-990000000-00120.
    >> Share


  398. Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS: Erratum.
    J Hypertens. 2022;40:2084.
    >> Share

  399. ZHANG Z, Zhang X, Gui Y, Wang X, et al
    Renal arteriovenous fistula complicated with malignant hypertension: a case report.
    J Hypertens. 2022;40:2076-2080.
    >> Share

  400. TSAI HR, Hsu HC, Wu CI, Lee WH, et al
    Effects of postsystolic shortening and diastolic dyssynchrony on myocardial work in untreated early hypertension patients.
    J Hypertens. 2022;40:1994-2004.
    >> Share

  401. CHUANG KH, Yao RH, Jiang YN, Gui LX, et al
    Attenuating effect of magnesium on pulmonary arterial calcification in rodent models of pulmonary hypertension.
    J Hypertens. 2022;40:1979-1993.
    >> Share

  402. PALATINI P, Mos L, Rattazzi M, Spinella P, et al
    Blood pressure response to standing is a strong determinant of masked hypertension in young to middle-age individuals.
    J Hypertens. 2022;40:1927-1934.
    >> Share

  403. ALMANSOOR ZR, Saxton SN
    Time-restricted feeding: a free and effective method of managing hypertension by ameliorating inflammation?
    J Hypertens. 2022;40:1899-1901.
    >> Share

  404. HITIJ JB
    A commentary on the article 'Antihypertensive drug treatment in white-coat hypertension: data from the Plaque Hypertension Lipid-Lowering Italian Study'.
    J Hypertens. 2022;40:1897-1898.
    >> Share

  405. MESSERLI FH, Bavishi C, Brguljan J, Burnier M, et al
    Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
    J Hypertens. 2022;40:1859-1875.
    >> Share

  406. FINSTERER J
    Blood pressure regulation is multifactorial in mitochondrial disorders.
    J Hypertens. 2022;40:2081.
    >> Share

  407. OKUMURA K, Obayashi K, Tai Y, Yamagami Y, et al
    Influence of depression on the association between colder indoor temperature and higher blood pressure.
    J Hypertens. 2022;40:2013-2021.
    >> Share

  408. WANG Y, Zhang WS, Hao YT, Jiang CQ, et al
    Changes in blood pressure and cardiovascular disease in middle-aged to older Chinese: the Guangzhou Biobank Cohort Study.
    J Hypertens. 2022;40:2005-2012.
    >> Share

  409. STERNBACH TJ, Harper S, Li X, Zhang X, et al
    Effects of indoor and outdoor temperatures on blood pressure and central hemodynamics in a wintertime longitudinal study of Chinese adults.
    J Hypertens. 2022;40:1950-1959.
    >> Share

  410. SHARP ASP, Tunev S, Schlaich M, Lee DP, et al
    Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model.
    J Hypertens. 2022;40:2068-2075.
    >> Share

    September 2022
  411. FAN JF, Wang W, Tan X, Ye P, et al
    Contribution of cyclooxygenase-2 overexpression to enhancement in tonically active glutamatergic inputs to the rostral ventrolateral medulla in hypertension.
    J Hypertens. 2022 Sep 27. pii: 00004872-990000000-00119.
    >> Share

  412. ANGELAKI E, Barmparis GD, Kochiadakis G, Maragkoudakis S, et al
    Artificial intelligence-based opportunistic screening for the detection of arterial hypertension through ECG signals.
    J Hypertens. 2022 Sep 27. pii: 00004872-990000000-00118.
    >> Share

  413. LI C, Shang S, Liang W
    Sleep and risk of hypertension in general American adults: the National Health and Nutrition Examination Surveys (2015-2018).
    J Hypertens. 2022 Sep 20. pii: 00004872-990000000-00117.
    >> Share

  414. SENDZIKAITE S, Sudikiene R, Lubaua I, Silis P, et al
    Antihypertensive therapy of late arterial hypertension in children following successful coarctation correction.
    J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00115.
    >> Share

  415. LIAN J, Shi X, Jia X, Fan J, et al
    Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
    J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00114.
    >> Share

  416. CHANDAK P, Kessaris N, Karunanithy N, Byrne N, et al
    Utilizing 3D printing to facilitate surgical in-situ paediatric renal artery aneurysm repair for refractory hypertension.
    J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00113.
    >> Share


  417. Hyperuricemia and risk of hypertension resistant to therapy: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2022;40:1845.
    >> Share

  418. LI C, Wang Q, Qing Y, Ma L, et al
    Rho kinase inhibition on renal remodeling in an apatinib-induced hypertensive rat model.
    J Hypertens. 2022;40:1838-1840.
    >> Share

  419. CALO LA, Stefanelli LF, Bertoldi G, Ravarotto V, et al
    Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more.
    J Hypertens. 2022;40:1836-1837.
    >> Share

  420. LIU Y, Zhong C, Si J, Chen S, et al
    The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive rats.
    J Hypertens. 2022;40:1822-1830.
    >> Share

  421. QU Y, Guo ZN, Zhang P, Ma HY, et al
    Time course of beat-to-beat blood pressure variability and outcome in patients with spontaneous intracerebral haemorrhage.
    J Hypertens. 2022;40:1744-1750.
    >> Share

  422. CHAMBERS LC, Diaz-Otero JM, Fisher CL, Jackson WF, et al
    Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension.
    J Hypertens. 2022;40:1722-1734.
    >> Share

  423. LIU MM, Peng J, Xu RX, Guo YL, et al
    Hypertension and clinical outcomes in patients with familial hypercholesterolemia.
    J Hypertens. 2022;40:1713-1721.
    >> Share

  424. LAU D, Ringrose J, McAlister FA, Fradette M, et al
    Telemonitoring and protocolized case management for hypertensive community dwelling older adults (TECHNOMED): a randomized controlled trial.
    J Hypertens. 2022;40:1702-1712.
    >> Share

  425. HITIJ JB
    Association of depressive symptoms and hypertension prevalence, awareness, treatment.
    J Hypertens. 2022;40:1655-1657.
    >> Share

  426. JIN X, Narisawa M, Piao L, Cheng XW, et al
    Protein tyrosine phosphatase receptor type D as a potential therapeutic target in pulmonary artery hypertension.
    J Hypertens. 2022;40:1650-1654.
    >> Share

  427. LEE EK, Zhu M, Chan DC, Yip BH, et al
    Comparing effect of definition of diurnal periods by diary, fixed periods, and actigraphy on ambulatory blood pressure parameters in a Chinese population.
    J Hypertens. 2022;40:1815-1821.
    >> Share

  428. BOGAERTS JMK, Poortvliet RKE, van der Klei VMGTH, Achterberg WP, et al
    Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysis.
    J Hypertens. 2022;40:1786-1794.
    >> Share

    August 2022
  429. GEWA CA, Onyango AC, Opiyo RO, Gittelsohn J, et al
    Patterns and predictors of elevated blood pressure and hypertension among primary school children in urban Kenya.
    J Hypertens. 2022 Aug 30. pii: 00004872-990000000-00111.
    >> Share

  430. ARAUJO-CASTRO M, Paja Fano M, Gonzalez Boillos M, Pla Peris B, et al
    Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score.
    J Hypertens. 2022 Aug 24. pii: 00004872-990000000-00101.
    >> Share

  431. LEE YH, Kim JS, Song SH, Song SH, et al
    Impact of donor hypertension on graft survival and function in living and deceased donor kidney transplantation: a nationwide prospective cohort study.
    J Hypertens. 2022 Aug 24. pii: 00004872-990000000-00103.
    >> Share

  432. KWON CH, Lee HY, Lee JH, Kim M, et al
    Optimal office blood pressure levels in younger (<50 years old) Korean hypertensive patients: a nationwide cohort study in South Korea.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00091.
    >> Share

  433. GRONEWOLD J, Jokisch M, Schramm S, Himpfen H, et al
    Periventricular rather than deep white matter hyperintensities mediate effects of hypertension on cognitive performance in the population-based 1000BRAINS study.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00086.
    >> Share

  434. SALICE P, Mircoli L, Butera G, Burdick L, et al
    Percutaneous cutting balloon angioplasty for the treatment of renovascular hypertension in children and adolescents.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00089.
    >> Share

  435. HATA S, Ushigome E, Yoshimura T, Takegami M, et al
    Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00088.
    >> Share

  436. GAFFEY AE, Rosman L, Sico JJ, Haskell SG, et al
    Military sexual trauma and incident hypertension: A 16-year cohort study of young and middle-aged men and women.
    J Hypertens. 2022 Aug 18. pii: 00004872-990000000-00085.
    >> Share

  437. STERGIOU G, Brunstrom M, MacDonald T, Kyriakoulis KG, et al
    Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
    J Hypertens. 2022 Aug 16. pii: 00004872-990000000-00084.
    >> Share

  438. VELDHUIZEN GP, Alnazer RM, Kroon AA, de Leeuw PW, et al
    Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00078.
    >> Share

  439. KABIA AU, Li P, Jin Z, Tan X, et al
    The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00080.
    >> Share

  440. IATRIDI F, Theodorakopoulou MP, Papagianni A, Sarafidis P, et al
    Management of intradialytic hypertension: current evidence and future perspectives.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00071.
    >> Share

  441. ZHENG X, Han L, Shen S
    Hypertension, remnant cholesterol and cardiovascular disease: evidence from the China health and retirement longitudinal study.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00079.
    >> Share

  442. LI J, Tong D, Song B, Xie F, et al
    Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00070.
    >> Share

  443. KANG MY
    Occupational risk factors for hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00074.
    >> Share

  444. FALLO F, Di Dalmazi G, Beuschlein F, Biermasz NR, et al
    Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00081.
    >> Share

  445. COSTA TJ, Linder BA, Hester S, Fontes M, et al
    The janus face of ketone bodies in hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00064.
    >> Share

  446. LIN Y, Li YQ, Wang H, Wu HJ, et al
    Increasing angiotensin-converting enzyme 1 regulated by histone 3 lysine 27 hyperacetylation in high-fat diet-induced hypertensive rat kidney.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00065.
    >> Share

  447. GEORGE R, Thomas C, Joy CA, Varghese B, et al
    Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00069.
    >> Share

  448. FANG X, Ma L, Wang Y, Ren F, et al
    Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.
    J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00062.
    >> Share

  449. NAKAGAWA K, Chen R, Greenberg SM, Ross GW, et al
    Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage.
    J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00061.
    >> Share

  450. TABARA Y, Chin K
    Sleep duration and sleep blood pressure: the Nagahama study.
    J Hypertens. 2022;40:1624-1625.
    >> Share

  451. WARD NC, Carnagarin R, Nolde JM, Lugo-Gavidia LM, et al
    Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes.
    J Hypertens. 2022;40:1589-1596.
    >> Share

  452. NARITA K, Hoshide S, Ae R, Kario K, et al
    Simple predictive score for nocturnal hypertension and masked nocturnal hypertension using home blood pressure monitoring in clinical practice.
    J Hypertens. 2022;40:1513-1521.
    >> Share

  453. CUKA E, Simonini M, Lanzani C, Zagato L, et al
    Inverse salt sensitivity: an independent risk factor for cardiovascular damage in essential hypertension.
    J Hypertens. 2022;40:1504-1512.
    >> Share

  454. JIMENEZ-BALADO J, Riba-Llena I, Nafria C, Pizarro J, et al
    Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension.
    J Hypertens. 2022;40:1469-1477.
    >> Share

  455. SATOH M, Hirose T, Satoh H, Nakayama S, et al
    Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients.
    J Hypertens. 2022;40:1564-1576.
    >> Share

    July 2022
  456. SAVARE L, Rea F, Corrao G, Mancia G, et al
    Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian database.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00054.
    >> Share

  457. JONES S, Schultz MG, Park C, Tillin T, et al
    Antihypertensive treatment effect on exercise blood pressure and exercise capacity in older adults.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00058.
    >> Share

  458. CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
    Arterial stiffness and nocturnal hypertension in preterm children and adolescents.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00055.
    >> Share

  459. MANCIA G, Facchetti R, Quarti-Trevano F, Grassi G, et al
    Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00056.
    >> Share

  460. MAGHAJOTHI S, Subramanian L, Mani P, Singh M, et al
    A common Matrix metalloproteinase 8 promoter haplotype enhances the risk for hypertension via diminished interactions with nuclear factor kappa B.
    J Hypertens. 2022 Jul 25. pii: 00004872-990000000-00050.
    >> Share

  461. XU J, Zhong Y, Yin H, Linneman J, et al
    Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCgamma1 axis.
    J Hypertens. 2022 Jul 14. pii: 00004872-990000000-00040.
    >> Share

  462. SIMS BM, Goodlett BL, Allbee ML, Pickup EJ, et al
    Time restricted feeding decreases renal innate immune cells and blood pressure in hypertensive mice.
    J Hypertens. 2022 Jul 12. pii: 00004872-990000000-00037.
    >> Share

  463. AGBAJE AO
    Arterial stiffness precedes hypertension and metabolic risks in youth: a review.
    J Hypertens. 2022 Jul 11. pii: 00004872-990000000-00039.
    >> Share

  464. POUDEL B, Viera AJ, Shimbo D, Schwartz JE, et al
    Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00030.
    >> Share

  465. ZHU Y, Tao Y, Wu C, Zeng Y, et al
    Renal Farnesoid X Receptor improves high fructose-induced salt-sensitive hypertension in mice by inhibiting DNM3 to promote nitro oxide production.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00029.
    >> Share

  466. SRIVASTAVA S, Vemulapalli B, Okoh AK, Kassotis J, et al
    Disparity in hospital admissions and length of stay based on income status for emergency department hypertensive crisis visits.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00024.
    >> Share

  467. THEODORAKOPOULOU MP, Karagiannidis AG, Alexandrou ME, Polychronidou G, et al
    Sex differences in ambulatory blood pressure levels, control and phenotypes of hypertension in hemodialysis patients.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00031.
    >> Share

  468. DU TOIT WL, Kruger R, Gafane-Matemane LF, Schutte AE, et al
    Urinary metabolomics profiling by cardiovascular risk factors in young adults: the African Prospective study on Early Detection and Identification of Cardiovascular disease and Hypertension study.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00032.
    >> Share

  469. FANG J, Zhang Z, Greenlund KJ
    Association of depressive symptoms and hypertension prevalence, awareness, treatment and control among USA adults.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00035.
    >> Share

  470. BIRUKOV A, Glintborg D, Schulze MB, Jensen TK, et al
    Elevated blood pressure in pregnant women with gestational diabetes according to the WHO criteria: importance of overweight.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00028.
    >> Share

  471. SOHN CS, Chang JW, George B, Chen S, et al
    Role of the angiotensin type 1 receptor in modulating the carotid chemoreflex in an ovine model of renovascular hypertension.
    J Hypertens. 2022;40:1421-1430.
    >> Share

  472. CAVAGNA P, Kramoh KE, Diop IB, Kouam Kouam C, et al
    Barriers to up-titrated antihypertensive strategies in 12 sub-Saharan African countries: the Multination Evaluation of hypertension in Sub-Saharan Africa Study.
    J Hypertens. 2022;40:1411-1420.
    >> Share

  473. KYRIAKOULIS KG, Ntineri A, Niiranen TJ, Lindroos A, et al
    Home blood pressure monitoring schedule: optimal and minimum based on 2122 individual participants' data.
    J Hypertens. 2022;40:1380-1387.
    >> Share

  474. AZUKAITIS K, Sinha MD, Obrycki L, Pac M, et al
    Disparities between determinants of impaired vascular structure and function in young people with primary hypertension: a systematic review.
    J Hypertens. 2022;40:1369-1379.
    >> Share

  475. AN H, Jin M, Li Z, Zhang L, et al
    Association of gestational hypertension and preeclampsia with nonsyndromic orofacial clefts in China: a large prospective cohort study.
    J Hypertens. 2022;40:1352-1358.
    >> Share

  476. TATSUMI Y, Satoh M, Asayama K, Murakami T, et al
    Association of home and office systolic and diastolic hypertension with glucose metabolism in a general population: the Ohasama study.
    J Hypertens. 2022;40:1336-1343.
    >> Share

  477. CHEDIER B, Roderjan CN, Cavalcanti AH, de Souza F, et al
    Prevalence and associated factors of obstructive sleep apnea in refractory hypertension.
    J Hypertens. 2022;40:1327-1335.
    >> Share

  478. ARIFEN N, Li Y, Srivastava AK, Anand-Srivastava MB, et al
    Sirtuin1 inhibitor attenuates hypertension in spontaneously hypertensive rats: role of Gialpha proteins and nitroxidative stress.
    J Hypertens. 2022;40:1314-1326.
    >> Share

  479. ANTZA C, Stabouli S, Kotsis V
    Practical guide for the management of hypertensive disorders during pregnancy.
    J Hypertens. 2022;40:1257-1264.
    >> Share

  480. KALAGARA R, Chennareddy S, Scaggiante J, Matsoukas S, et al
    Blood pressure management through application-based telehealth platforms: a systematic review and meta-analysis.
    J Hypertens. 2022;40:1249-1256.
    >> Share

    June 2022
  481. LIAO Y, Chu C, Wang Y, Zheng W, et al
    Isolated diastolic hypertension in childhood and risk of adult subclinical target organ damage: a 30-year prospective cohort study.
    J Hypertens. 2022 Jun 22. pii: 00004872-990000000-00010.
    >> Share

  482. OGGERO S, Godec T, van Gorp R, Pinto LA, et al
    Role of plasma extracellular vesicles in prediction of cardiovascular risk and alterations in response to statin therapy in hypertensive patients.
    J Hypertens. 2022 Jun 22. pii: 00004872-990000000-00012.
    >> Share

  483. STERGIOU GS, Mukkamala R, Avolio A, Kyriakoulis KG, et al
    Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2022 Jun 17. pii: 00004872-990000000-00007.
    >> Share

  484. POTHURU S, Chan WC, Ranka S, Acharya P, et al
    Epidemiology and outcomes of hypertensive crisis in patients with chronic kidney disease: a nationwide analysis.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00003.
    >> Share

  485. SMITH PJ, Andrew S, Hinderliter AL, Mabe S, et al
    Lifestyle modification and cognitive function among individuals with resistant hypertension: cognitive outcomes from the TRIUMPH trial.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00005.
    >> Share

  486. MARQUES-VIDAL P, Chekanova V, Vaucher J
    Association between genetic risk of high SBP and hypertension control: the CoLaus|PsyColaus study.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00002.
    >> Share

  487. BERILLO O, Huo KG, Richer C, Fraulob-Aquino JC, et al
    Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00006.
    >> Share


  488. Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2022;40:1248.
    >> Share

  489. RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
    Prevalence, time-trends and clinical characteristics of hypertension in young adults: nationwide cross-sectional study of 1.7 million Swedish 18-year-olds, 1969-2010.
    J Hypertens. 2022;40:1231-1238.
    >> Share

  490. SADANANTHAN SA, Michael N, Tint MT, Thirumurugan K, et al
    Associations of maternal periconceptional alcohol consumption with offspring prehypertension/hypertension at age 6 years: the Growing Up in Singapore Towards healthy Outcomes prospective mother-offspring cohort study.
    J Hypertens. 2022;40:1212-1222.
    >> Share

  491. FERMOYLE CC, Broxterman RM, La Salle DT, Ratchford SM, et al
    Persistent vascular dysfunction following an acute nonpharmacological reduction in blood pressure in hypertensive patients.
    J Hypertens. 2022;40:1115-1125.
    >> Share

  492. ABRAHIN O, Abrahin RP, de Sousa EC, Cortinhas-Alves EA, et al
    Inter-individual variations in response to aerobic and resistance training in hypertensive older adults.
    J Hypertens. 2022;40:1090-1098.
    >> Share

  493. ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
    Reproducibility of masked hypertension and office-based hypertension: a systematic review and meta-analysis.
    J Hypertens. 2022;40:1053-1059.
    >> Share

  494. ALIMENTO ML, Palermo P, Italiano G, Antonioli L, et al
    Can beta-blockers influence regular daily physical activity?
    J Hypertens. 2022;40:1199-1203.
    >> Share

  495. KOU C, Zhao X, Lin X, Fan X, et al
    Effect of different treatments for obstructive sleep apnoea on blood pressure.
    J Hypertens. 2022;40:1071-1084.
    >> Share

  496. GUTTERIDGE DS, Tully PJ, Ghezzi ES, Jamadar S, et al
    Blood pressure variability and structural brain changes: a systematic review.
    J Hypertens. 2022;40:1060-1070.
    >> Share

  497. AUNE A, Gerdts E, Kokorina M, Kringeland E, et al
    Persistent cardiac organ damage in surgically and medically treated primary aldosteronism.
    J Hypertens. 2022;40:1204-1211.
    >> Share

  498. BUFFOLO F, Burrello J, Burrello A, Heinrich D, et al
    DEVELOPMENT OF CLINICAL SCORING SYSTEM AND MACHINE LEARNING-BASED MODEL TO PREDICT DIAGNOSIS OF PRIMARY ALDOSTERONISM IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  499. ZHOU H, Wang X, Chen Z, Zhang L, et al
    EFFECT OF A WEB-BASED MANAGEMENT PLATFORM ON HYPERTENSION CONTROL IN COMMUNITY: A RANDOMIZED CLINICAL TRIAL.
    J Hypertens. 2022;40.
    >> Share

  500. UAGBOE AA, Ogboye A, Munee MM, Rahman KJ, et al
    LEVERAGING TECHNOLOGY TO SUPPORT PEOPLE LIVING WITH HYPERTENSION AND DIABETES DURING THE COVID-19 PANDEMIC.
    J Hypertens. 2022;40.
    >> Share

  501. LUQUE P, Castilla-Guerra L, Sanchez N, Delgado M, et al
    THE IMPACT OF HYPERTENSION AND ANTIHIPERTENSIVE TREATMENTS ON PATIENTS WITH SARS-COV-2: A RETROSPECTIVE-COHORT STUDY.
    J Hypertens. 2022;40.
    >> Share

  502. SHALAEVA E, Shamsutdinova M, Shadmanov A, Boymuradov S, et al
    COVID-19 AND NEW ONSET HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  503. WEBER T, Kreutz R, Januszewicz A, Mayer C, et al
    COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  504. CANDUSSO G, Catena C, Soardo G, Baiano V, et al
    NON-INVASIVE BIOCHEMICAL SCORES OF NAFLD AND CAROTID MORPHOFUNCTIONAL ALTERATIONS IN NEVER TREATED ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  505. AZUKAITIS K, Rus R, Sagsak E, Jankauskiene A, et al
    SYSTOLIC AND DIASTOLIC LEFT VENTRICULAR DYSFUNCTION IN CHILDREN WITH PRIMARY HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  506. MYETTE R, Obrycki L, Litwin M, Seeman T, et al
    THE PREVALENCE AND IMPACT OF ISOLATED DIASTOLIC HYPERTENSION IN CHILDREN.
    J Hypertens. 2022;40.
    >> Share

  507. SKRZYPCZYK P, Ofiara A, Szyszka M, Wabik A, et al
    CIRCADIAN BLOOD PRESSURE PROFILE IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  508. SKRZYPCZYK P, Pawlik K, Bujanowicz A, Wroniewicz T, et al
    LIPID INDICES, ARTERIAL DAMAGE AND ALBUMINURIA IN PEDIATRIC PATIENTS WITH UNTREATED PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  509. SZYSZKA M, Skrzypczyk P, Ofiara A, Wabik A, et al
    COMMON CAROTID ARTERY ELASTICITY, INTIMA-DIAMETER RATIO, AND TENSILE STRESS IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  510. ARNOLDI C, Capellini S, Zuccotti L, Paini A, et al
    RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND HYPERTENSION MEDIATED ORGAN DAMAGE: THE VOBARNO STUDY.
    J Hypertens. 2022;40.
    >> Share

  511. DE LA COLINA AN, Vasiliadis HM, Berbiche D, Bherer L, et al
    IMPACT OF SEX AND ANTIHYPERTENSIVE MEDICATION ON GLOBAL COGNITION IN PRIMARY CARE OLDER ADULTS.
    J Hypertens. 2022;40.
    >> Share

  512. SUKHAREVA A, Falkovskaya A, Baev AE, Mochula OV, et al
    MRI IN THE ASSESSMENT OF CEREBRAL INJURY AND CEREBROPROTECTIVE EFFECTS OF RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  513. TRIANTAFYLLOU G, Triantafyllou A, Dipla K, Zafeiridis A, et al
    ASSOCIATION OF CEREBRAL OXYGENATION DURING EXERCISE WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE AND NORMOTENSIVE INDIVIDUALS.
    J Hypertens. 2022;40.
    >> Share

  514. LIAKOS C, Karpanou E, Markou M, Grassos C, et al
    SYNERGISTIC EFFECT OF HIGH HOMOCYSTEINE AND LOW VITAMIN B12 LEVELS ON CARDIOVASCULAR AND STROKE RISK OF HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  515. NGUYEN K, Abrahams N, Jewkes R, Mhlongo S, et al
    EXPOSURES TO INTIMATE PARTNER VIOLENCE AND NON-PARTNER SEXUAL VIOLENCE ARE ASSOCIATED WITH HYPERTENSION IN SOUTH AFRICAN WOMEN.
    J Hypertens. 2022;40.
    >> Share

  516. PALATINI P, Mos L, Rattazzi M, Vriz O, et al
    ORTHOSTATIC HYPERREACTIVITY AND THE CARDIOVASCULAR RISK IN JUVENILE AND MIDDLE-AGE HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  517. THEODORAKOPOULOU M, Iatridi F, Alexandrou ME, Karpetas A, et al
    THE INFLUENCE OF AMBULATORY BLOOD PRESSURE ON THE ASSOCIATIONS OF INTRADIALYTIC HYPERTENSION WITH FUTURE CARDIOVASCULAR EVENTS AND MORTALITY IN HEMODIALYSIS PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  518. KHOMOVA I, Khramkova A, Shavarova E, Ezhova N, et al
    ASSOCIATIONS BETWEEN EPICARDIAL FAT AND LEFT VENTRICULAR GEOMETRY IN YOUNG NON-OBESE HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  519. NARITA K, Hoshide S, Kario K
    SIMPLE PREDICTIVE SCORE FOR NOCTURNAL HYPERTENSION AND MASKED NOCTURNAL HYPERTENSION USING HOME BLOOD PRESSURE MONITORING IN CLINICAL PRACTICE.
    J Hypertens. 2022;40.
    >> Share

  520. QUARTI-TREVANO F, Seravalle G, Dell'Oro R, Facchetti R, et al
    ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS).
    J Hypertens. 2022;40.
    >> Share

  521. RATTAZZI M, Saladini F, Mos L, Fania C, et al
    BLOOD PRESSURE RESPONSE TO STANDING IS A STRONG PREDICTOR OF MASKED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  522. SERAVALLE G, Facchetti R, Vanoli J, Dell'oro R, et al
    WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE.
    J Hypertens. 2022;40.
    >> Share

  523. CONSTANTINOS K, Stevens R, Hobbs FDR, McManus RJ, et al
    PREDICTING THE RISK OF SYNCOPE IN PATIENTS WITH AN INDICATION FOR ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-SYNCOPE PREDICTION MODEL.
    J Hypertens. 2022;40.
    >> Share

  524. NADERI H, Ramirez J, Van Duijvenboden S, Aung N, et al
    PREDICTING THE PATTERN OF ANATOMICAL LEFT VENTRICULAR HYPERTROPHY USING ELECTROPHYSIOLOGICAL BIOMARKERS FROM THE ECG QRS COMPLEX IN HYPERTENSIVE INDIVIDUALS FROM UK BIOBANK.
    J Hypertens. 2022;40.
    >> Share

  525. KJELDSEN SE, Zachs ES, Stokke IM, Wachtell K, et al
    TIME-VARYING SERUM URIC ACID PREDICTS NEW-ONSET ATRIAL FIBRILLATION IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  526. BOGAERTS J, Gussekloo J, De Jong-Schmit B, Achterberg W, et al
    THE DANTON STUDY - DISCONTINUATION OF ANTIHYPERTENSIVE TREATMENT IN OLDER PEOPLE WITH DEMENTIA LIVING IN A NURSING HOME: RESULTS OF A RANDOMIZED CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  527. RANCEVIENE D, Azukaite J, Rysevaite-Kyguoliene K, Pauziene N, et al
    IMPACT OF ARTERIAL HYPERTENSION VERSUS AGING TO THE STRUCTURES OF EPICARDIAC NERVES IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  528. MENDEZ I, Saiz LC, Leache L, Gutierrez M, et al
    BLOOD PRESSURE TARGETS AND MORTALITY IN HYPERTENSIVE PATIENTS WITH CHRONIC RENAL DISEASE. SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  529. BERGLUND J, Wijkman MO, Nilsson S
    HIGHER PREVALENCE OF MASKED UNCONTROLLED HYPERTENSION WITH NEW EUROPEAN BLOOD PRESSURE TARGETS IN AN ELDERLY PRIMARY CARE POPULATION.
    J Hypertens. 2022;40.
    >> Share

  530. BURTSEV Y, Boytsov S, Karpov Y, Khomitskaya Y, et al
    EFFECTIVENESS AND TOLERABILITY OF BISOPROLOL/PERINDOPRIL SINGLE-PILL COMBINATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND CONCOMITANT HYPERTENSION WHO HAD A HISTORY OF MIOCARDIAL INFARCTION.
    J Hypertens. 2022;40.
    >> Share

  531. GRECA E, Wireko AA, Abdul-Rahman T, Kacimi SEO, et al
    ANTI-INFLAMMATORY EFFECTS AND PPAR GAMMA-ACTIVATING PROPERTIES OF TELMISARTAN IN PATIENTS WITH THE HYPERTENSION'S ON METABOLIC SYNDROME: METANALYSIS OF RCT.
    J Hypertens. 2022;40.
    >> Share

  532. KOVAL S, Penkova M, Mysnychenko O, Reznik L, et al
    AMBULATORY BLOOD PRESSURE MONITORING PARAMETERS IN HYPERTENSIVE PATIENTS WITH ABDOMINAL OBESITY IN THE DYNAMICS OF OLMESARTAN/ AMLODIPINE THERAPY.
    J Hypertens. 2022;40.
    >> Share

  533. LEITE V, Abecasis F, Beirao P, Cunha V, et al
    INTENSIVE SYSTOLIC BLOOD PRESSURE TARGET IN OLDER HYPERTENSIVE PATIENTS - IS IT BENEFICIAL?
    J Hypertens. 2022;40.
    >> Share

  534. PEI Y, Yu J
    EFFECT OF SACUBITRIL-VALSARTAN ON EARLY RENAL FUNCTION AND VASCULAR FUNCTION IN PATIENTS DURING PERIMENOPAUSE WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  535. BARRAGAN ACP, Leiva VG, Espejel LD
    REACHING OF THERAPEUTICS GOALS IN PATIENTS WITH HYPERTENSION AND DIABETES MELLITUS. DO MULTIPLE THERAPY WORKS?
    J Hypertens. 2022;40.
    >> Share

  536. ZBYSHEVSKAYA E, Makeeva T, Gumerova V, Erinchek V, et al
    VASCULAR STIFFNESS AS AN TARGET OF OPTIMAL ANTIHYPERTENSIVE THERAPY.
    J Hypertens. 2022;40.
    >> Share

  537. ZHUANG C, Wang W, Sun R, Qi M, et al
    SACUBITRIL/VALSARTAN IMPROVES SEXUAL FUNCTION AND FIBROSIS OF THE CLITORAL AND VAGINAL TISSUES IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  538. AJOSE A, Odukoya OO, Akodu B
    PERCEIVED STRESS, DEPRESSION AND MEDICATION ADHERENCE AMONG HYPERTENSIVE PATIENTS ATTENDING A SECONDARY CARE HOSPITAL IN LAGOS, NIGERIA.
    J Hypertens. 2022;40.
    >> Share

  539. JUG J, Prkacin I
    ADHERENCE TO THE ANTIHYPERTENSIVE THERAPY - A VIEW FROM THE FAMILY MEDICINE PERSPECTIVE.
    J Hypertens. 2022;40.
    >> Share

  540. PAPPACCOGLI M, Georges CM, Petit G, Ritscher S, et al
    DRUG ADHERENCE AND PSYCHOLOGICAL FACTORS MATTER IN PATIENTS WITH RESISTANT HYPERTENSION - YES BUT WHICH ONES?
    J Hypertens. 2022;40.
    >> Share

  541. BUFFOLO F, Sconfienza E, Burrello J, Losano I, et al
    ESTIMATE OF ANTI-HYPERTENSIVE DRUG ADHERENCE THROUGH SERIAL MEASUREMENTS OF ALDOSTERONE-TO-RENIN RATIO.
    J Hypertens. 2022;40.
    >> Share

  542. COELHO J, Guimaraes M, Dos Santos J, Vaz A, et al
    ADHERENCE TO ANTIHYPERTENSIVE DRUG TREATMENT IN BRAZIL: SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  543. HALVORSEN LV, Gognstad S, Soraas CL, Agnes C, et al
    IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  544. LEE EK, Poon P, Bo Y, Zhu MT, et al
    GLOBAL BURDEN, REGIONAL DIFFERENCES, TRENDS, AND HEALTH CONSEQUENCES OF MEDICATION NON-ADHERENCE IN PATIENTS WITH HYPERTENSION DURING 2010-2020: A SYSTEMATIC REVIEW AND META-ANALYS.
    J Hypertens. 2022;40.
    >> Share

  545. LEITE V, Coelho RP, Abecasis F, Beirao P, et al
    HYPERTENSIVE CRISIS AT THE EMERGENCY DEPARTMENT OF A CENTRAL HOSPITAL.
    J Hypertens. 2022;40.
    >> Share

  546. LOPES S, Diniz F, Oliveira J, Mesquita-Bastos J, et al
    RESISTANT HYPERTENSION PATIENTS' PERSPECTIVES ABOUT AN AEROBIC EXERCISE PROGRAM: INSIGHTS FROM THE ENRICH TRIAL.
    J Hypertens. 2022;40.
    >> Share

  547. MONTEALEGRE L, Navarro G, Amador E, Arteta M, et al
    BELIEFS IN HEALTH AND ADHERENCE TO TREATMENT IN HYPERTENSIVE PATIENTS IN BARRANQUILLA- COLOMBIA.
    J Hypertens. 2022;40.
    >> Share

  548. MONTEALEGRE L, Amador E, Pulido T, Cabrera C, et al
    MAIN FACTORS THAT DETERMINE ADHERENCE TO PHARMACOLOGICAL TREATMENT IN HYPERTENSIVE PATIENTS. SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  549. OLIVERAS A, Galceran I, Camps C, Faura A, et al
    MEDICATION NON-ADHERENCE IN UNCONTROLLED HYPERTENSION: SELECTIVE DETECTION AND EFFICIENCY AND EFFECTIVENESS OF A PROGRAM TO IMPROVE COMPLIANCE (ATHAN TRIAL).
    J Hypertens. 2022;40.
    >> Share

  550. PEETERS L, Kappers MHW, Hesselink DA, Net JBV, et al
    RESISTANT HYPERTENSION IMPROVED AFTER 3 AND 6 MONTHS BY MEASURING DRUG LEVELS TO IDENTIFY NON-ADHERENCE.
    J Hypertens. 2022;40.
    >> Share

  551. RENNA N, Diez E, Vissani S, Farez B, et al
    ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A POPULATION OF ARGENTINA DURING THE COVID-19 PANDEMIC.
    J Hypertens. 2022;40.
    >> Share

  552. RIETZSCHEL E, Descamps O, De Sutter J, Philips JC, et al
    ATHERO: AN OBSERVATIONAL CROSS-SECTIONAL EVALUATION OF ATHEROSCLEROTIC RISK CONTROL IN THE BELGIAN POPULATION TREATED WITH AT LEAST ONE ANTIHYPERTENSIVE AND ONE LIPID-LOWERING DRUG.
    J Hypertens. 2022;40.
    >> Share

  553. POLACZYK M, Olszanecka A, Wojciechowska W, Rajzer M, et al
    MULTIPLE DRUG INTOLERANCE IN PATIENTS WITH ARTERIAL HYPERTENSION: PREVALENCE AND DETERMINING FACTORS.
    J Hypertens. 2022;40.
    >> Share

  554. TARNOVSKI L, Frkanec S, Frkanec S, Katic L, et al
    THE PHARMACISTS' AND MOBILE APPLICATIONS' ROLE IN THE TREATMENT OF HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  555. FRAGOULIS C, Prentakis AG, Kontogianni E, Polyzos D, et al
    DEPENDENCY RELATIONSHIP OF EXERCISE AND MEDICATION ADHERENCE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  556. YOUSSEF G, Mohamed M, Remisy DE, Hamid MA, et al
    REASONS OF NON-COMPLIANCE TO OFFICE VISITS IN HYPERTENSIVE PATIENTS: RESULTS FROM THE REGISTRY OF SPECIALIZED HYPERTENSION CLINICS.
    J Hypertens. 2022;40.
    >> Share

  557. HUANG JF, Zhang DY, An DW, Li MX, et al
    ANTIHYPERTENSIVE TREATMENT IN MASKED HYPERTENSION FOR TARGET ORGAN PROTECTION (ANTI-MASK): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  558. BAGADIA L
    A RANDOMIZED CONTROLLED TRIAL OF INDIVIDUALIZED HOMOEOPATHIC TREATMENT TO REDUCE ANGER & THEREBY REDUCING HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  559. FILHO GG, Inuzuka S, Vitorino P, Sousa ALL, et al
    PHARMACOLOGICAL TREATMENT OF ARTERIAL HYPERTENSION GUIDED BY PERIPHERAL OR CENTRAL BLOOD PRESSURE: COMPARISON OF THE TWO STRATEGIES IN THE INCIDENCE OF INTERMEDIATE OUTCOMES.
    J Hypertens. 2022;40.
    >> Share

  560. KONRADI A, Hassan H, Lefay D, Isachenko E, et al
    CLINICAL EFFICACY AND SAFETY OF AMLODIPINE/BISOPROLOL/PERINDOPRIL SINGLE-PILL AND FREE COMBINATION THERAPY IN PATIENTS WITH UNCONTROLLED ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  561. JARAI Z, Amon T, Baracsi-Botos V, Meszaros A, et al
    TELMISARTAN/AMLODIPINE SINGLE-PILL COMBINATION THERAPY TO ACHIEVE BLOOD PRESSURE GOAL VALUES IN HYPERTENSIVE PATIENTS IN GPS' PRACTICE - AN OBSERVATIONAL STUDY.
    J Hypertens. 2022;40.
    >> Share

  562. KAM E, Lee P, Poon P, Yu CP, et al
    CONTROLLED-RELEASED ORAL MELATONIN SUPPLEMENTATION FOR HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  563. GUO Q, Lin J, Peng F, Chai D, et al
    CARDIOVASCULAR OUTCOMES OF INITIAL BETA-BLOCKER + CALCIUM CHANNEL BLOCKER THERAPY VS OTHER DUAL THERAPIES IN CHINESE PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION: A REAL-WORLD STUDY.
    J Hypertens. 2022;40.
    >> Share

  564. LOPES S, Mesquita-Bastos J, Garcia C, Oliveira J, et al
    ACUTE AEROBIC EXERCISE-INDUCED DECREASE IN BLOOD PRESSURE IS ASSOCIATED WITH CHRONIC BLOOD PRESSURE CHANGES IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  565. MIKHAILOVA O, Elfimova E, Khachatryan N, Litvin A, et al
    PRESCRIBED ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH AND WITHOUT ITS "ESCAPE'' PHENOMENON.
    J Hypertens. 2022;40.
    >> Share

  566. MOURAD JJ, Jamet P, Huguet M, Loubiere M, et al
    TRIPLE ANTIHYPERTENSIVE THERAPY TYPE AND USE IN FRENCH GENERAL PRACTICE AND CARDIOLOGY IN 2021.
    J Hypertens. 2022;40.
    >> Share

  567. RADCHENKO G, Sirenko Y, Torbas O
    THE OPEN-LABEL MULTICENTRAL STUDY OF ANTIHYPERTENSIVE FIXED-DOSE COMBINATION EFFECTIVENESS IN UKRAINE.
    J Hypertens. 2022;40.
    >> Share

  568. SHEPPARD J, Koshiaris C, Stevens R, McManus R, et al
    THE ASSOCIATION BETWEEN ANTIHYPERTENSIVE TREATMENT AND SERIOUS ADVERSE EVENTS BY AGE AND FRAILTY: AN OBSERVATIONAL COHORT STUDY OF 3.8 MILLION PATIENTS FOLLOWED UP FOR 10 YEARS.
    J Hypertens. 2022;40.
    >> Share

  569. SHUPENINA E, Vasyuk Y, Namazova G
    OBSERVATIONAL PROSPECTIVE STUDY OF AZILSARTAN MEDOXOMIL/ CHLORTALIDONE COMPARED WITH IRBESARTAN/ HYDROCHLOROTHIAZIDE COMBINATION THERAPY IN OBESE HYPERTENSIVES (PUZZLE).
    J Hypertens. 2022;40.
    >> Share

  570. FRAGOULIS C, Polyzos D, Konstantinidis D, Mavroudis A, et al
    GENDER AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERTENSIVE CRISES AFTER 12-MONTH FOLLOW-UP: A GREEK REGISTRY.
    J Hypertens. 2022;40.
    >> Share

  571. KOUREMETI M, Iliakis P, Konstantinidis D, Polyzos D, et al
    EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS FROM HEBRO STUDY.
    J Hypertens. 2022;40.
    >> Share

  572. YU X, Xu R
    DAPAGLIFLOZIN'S EFFECT ON SERUM HOMOCYSTEINE IN PATIENTS WITH HYPERTENSION COMPLIACTED WITH INSULIN RESISTANCE.
    J Hypertens. 2022;40.
    >> Share

  573. BOULESTREAU R, Tillement J, Lucas L, Cremer A, et al
    IS HEADACHE AT ADMISSION ASSOCIATED WITH HIGHER RATE OF RECENT BRAIN MRI INJURY DURING MALIGNANT HYPERTENSION CRISIS?
    J Hypertens. 2022;40.
    >> Share

  574. LUIS CG, Linero PL, Moreno MDCF, Fito MS, et al
    TRENDS IN ANTIHYPERTENSIVE MEDICATION USE AFTER ISCHEMIC STROKE (1999-2020).
    J Hypertens. 2022;40.
    >> Share

  575. PINTO D, Rato ND, Garcia C, Teixeira M, et al
    ADHERENCE TO PHYSICAL ACTIVITY IN OLDER ADULTS WITH HYPERTENSION: LESSONS FROM THE HOLDAGE RANDOMIZED CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  576. NUNEZ URQUIZA JP, Marti A, Cervantes N, Reza APS, et al
    EVALUATION OF BLOOD PRESSURE CONTROL AND THE EFFECTIVENESS OF DIFFERENT ANTIHYPERTENSIVES BY MEANS OF THE STRESS TEST.
    J Hypertens. 2022;40.
    >> Share

  577. SENER YZ, Durukan BN, Ozcan EB, Kutukcu EC, et al
    EFFECTS OF LEFT VENTRICULAR MASS INDEX AND LEFT VENTRICULAR GEOMETRY ON 6 MINUTE STEPPER TEST RESULTS IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  578. NEMER CB, Chedier B, de Hollanda Cavalcanti A, Nejm Roderjan C, et al
    IMPACT OF LONG-TERM USE OF CPAP TREATMENT ON BLOOD PRESSURE AMONG REFRACTORY HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA.
    J Hypertens. 2022;40.
    >> Share

  579. RODERJAN CN, de Souza F, Chedier B, de Hollanda Cavalcanti A, et al
    EFFECT OF LONG-TERM USE OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT ON ARTERIAL STIFFNESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  580. DENISOVA A, Solntseva T, Sivakova O, Chazova I, et al
    FACTORS ASSOCIATED WITH AN INCREASED RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  581. FERRAO D, Silva C, Matos M, Ferreira S, et al
    VASCULITIS AND RENOVASCULAR HYPERTENSION - A CASE REPORT.
    J Hypertens. 2022;40.
    >> Share

  582. VARETA G, Georgianos P, Vaios V, Sgouropoulou V, et al
    PREVALENCE OF APPARENT-TREATMENT RESISTANT HYPERTENSION IN PERITONEAL DIALYSIS PATIENTS ASSESSED WITH THE USE OF 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING.
    J Hypertens. 2022;40.
    >> Share

  583. IONOV M, Emelyanov I, Vakhrushev A, Alieva A, et al
    RADIOFREQUENCY RENAL SYMPATHETIC DENERVATION WITH MULTIELECTRODE CATHETERS IN PATIENTS WITH RESISTANT HYPERTENSION: EARLY PROCEDURAL RESULTS.
    J Hypertens. 2022;40.
    >> Share

  584. KVAPIL T, Vaclavik J, Kocianova E, Benesova K, et al
    SHOULD ALL SECONDARY CAUSES OF HYPERTENSION BE SCREENED IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION?
    J Hypertens. 2022;40.
    >> Share

  585. MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
    A CLINICAL CASE OF SECONDARY HYPERTENSION IN A 20-YEAR-OLD FEMALE WITH COARCTATION OF THE AORTA.
    J Hypertens. 2022;40.
    >> Share

  586. MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
    SYSTEMIC VASCULAR RESISTANCE AS A PREDICTOR OF ANTIHYPERTENSIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  587. MATOVA O, Mishchenko L, Talaeva T
    CARDIOVASCULAR AND KIDNEY OUTCOMES IN TREATED RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  588. DE CARVALHO FORTES C, Chedier B, Roderjan CN, Viegas B, et al
    CHANGES IN CLINICAL PROFILE OF REFRACTORY HYPERTENSIVES AFTER THE INTRODUCTION OF SPIRONOLACTONE.
    J Hypertens. 2022;40.
    >> Share

  589. CHEDIER B, Souza F, Viegas B, Carlos FOC, et al
    PROGNOSTIC OF PATIENTS WITH REFRACTORY HYPERTENSION IN A COHORT OF RESISTANT HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  590. RAMIK Z, Vaclavik J, Kvapil T, Jelinek L, et al
    LONG TERM EFFECT OF RESISTANT ARTERIAL HYPERTENSION ON RENAL FUNCTION IN COMPARISON TO NON-RESISTANT ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  591. SHALIMOVA A, Isayeva G, Buriakovska O, Vovchenko M, et al
    DISTURBANCES OF THE CIRCADIAN RHYTHM AND BLOOD PRESSURE LEVELS IN OBESE PATIENTS WITH TRUE AND PSEUDO-RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  592. SOLNTSEVA T, Denisova A, Sivakova O, Chazova I, et al
    STATE OF TARGET ORGANS DAMAGE AND PREVALENCE OF CLINICAL ASSOCIATED CONDITIONS IN PATIENTS WITH A HYPERTENSIVE CRISIS AND UNCONTROLLED HYPERTENSION. (PILOT STUDY).
    J Hypertens. 2022;40.
    >> Share

  593. SUKHAREVA A, Falkovskaya A, Baev AE, Mochula OV, et al
    MRI POTENTIAL FOR PREDICTION OF THE ANTIHYPERTENSIVE EFFECT OF RFA IN PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  594. TABBALAT R, Al-Hayek T, Al Ani H, Barghouthi H, et al
    PRIMARY ALDOSTERONISM: INITIAL EXPERIENCE FROM A NEWLY ESTABLISHED ESH HYPERTENSION CENTER OF EXCELLENCE - WORK IN PROGRESS.
    J Hypertens. 2022;40.
    >> Share

  595. KUZIOR A, Hernandez-Lazaro A, De Leon-Durango R, Rios-Gomez C, et al
    EXTREMELY HIGH DIRECT PLASMA RENIN IN A YOUNG WOMAN WITH NEGATIVE IMAGING FOR RENOVASCULAR HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  596. BOSCH A, Poglitsch M, Kannenkeril D, Ott C, et al
    ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE.
    J Hypertens. 2022;40.
    >> Share

  597. BOULESTREAU R, Lorthioir A, Persu A, Cremer A, et al
    MALIGNANT HYPERTENSION HAMA COHORT: WHERE DO WE STAND IN 2021?
    J Hypertens. 2022;40.
    >> Share

  598. VISCHER A, Socrates T, Glinz D, Mayr M, et al
    ASSOCIATION OF BASELINE ALDOSTERONE/RENIN WITH MAGNITUDE OF BLOOD PRESSURE REDUCTION FROM FIRST-LINE TREATMENT IN TREATMENT-NAIVE HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  599. BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
    EVALUATION OF THE QUALITY OF SCREENING FOR HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  600. BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
    INFLUENCE OF FACTORS ON SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION IDENTIFIED DURING SCREENING.
    J Hypertens. 2022;40.
    >> Share

  601. BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
    THE INFLUENCE OF HEREDITY ON LIFESTYLE CHANGES AND PARTICIPATION IN SCHOOL OF CHRONIC PATIENTS IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  602. HUMBERT X, Rabiaza A
    PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS ARE INFLUENCED BY THE CHARACTERISTICS OF GENERAL PRACTITIONERS AND THEIR PATIENTS: A CROSS-SECTIONAL STUDY IN NORMANDY (FRANCE).
    J Hypertens. 2022;40.
    >> Share

  603. JUG J, Lang VB, Prkacin I
    ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSIVE CRISIS.
    J Hypertens. 2022;40.
    >> Share

  604. MOURAD JJ, Jamet P, Huguet M, Suhl J, et al
    ANTIHYPERTENSIVE TREATMENT INITIATION IN FRANCE: WHAT DID GENERAL PRACTITIONERS PRESCRIBE IN 2021?
    J Hypertens. 2022;40.
    >> Share

  605. GUIMIL PD, Herranz ED, Gonzalez ER, Testillano LM, et al
    WOMEN WITH HYPERTENSIVE STATES OF PREGNANCY FOLLOW IN NEPHROLOGY: CHARACTERISTICS AND EVOLUTION AFTER DELIVERY.
    J Hypertens. 2022;40.
    >> Share

  606. SOCRATES T, Wenker C, Blaschke C, Vischer A, et al
    FEASIBILITY, ACCEPTANCE AND SAFETY OF A HOME BASED TELEMONITORING STRATEGY IN WOMEN WITH POSTPARTUM HYPERTENSION. INTERIM ANALYSIS OF THE SWISS REGISTER FOR WOMEN WITH PPHT.
    J Hypertens. 2022;40.
    >> Share

  607. DA SILVA IV, Santos AC, Matos A, Ferreira J, et al
    AQUAPORIN-3 AND HEPARANASE GENETIC POLYMORPHISMS MAY MODULATE ANGIOGENESIS INFLUENCING THE RISK OF HYPERTENSIVE DISORDERS IN WOMEN.
    J Hypertens. 2022;40.
    >> Share

  608. STIRBAN R, Dragoi D, Grigore C, Balaceanu B, et al
    IT IS SOMETHING MAKING THE DIFFERENCE BETWEEN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME VERSUS HYPERTENSIVE PATIENTS WITHOUT METABOLIC SYNDROME IN SARS-COV-2 INFECTION?
    J Hypertens. 2022;40.
    >> Share

  609. CANTU SM, Lee HJ, Mikusic NLR, Kouyoumdzian NM, et al
    ALTERATION OF RENAL DOPAMINERGIC SYSTEM IN RATS FED WITH HIGH FAT DIET: A POSSIBLE MECHANISM PROMOTING ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  610. GASPAR L, Mesarosova D
    PECULIARITIES OF TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME.
    J Hypertens. 2022;40.
    >> Share

  611. KOKAEVA I, Zhernakova Y, Blinova N, Elfimova E, et al
    ENDOTHELIAL COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH OBESITY OR NORMAL BODY WEIGHT AFTER COVID-19.
    J Hypertens. 2022;40.
    >> Share

  612. KOVAL S, Snihurska I, Yushko K
    CHANGES IN THE COMPOSITION OF THE GUT MICROBIOTA IN THE OBESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  613. MASTROGIANNIS K, Lazaridis A, Triantafillou A, Koletsos N, et al
    CORRELATION OF COGNITIVE STATUS WITH IMPAIRED SKIN MICROVASCULAR REACTIVITY IN NEWLY DIAGNOSED UNTREATED HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  614. ZAMMANIS I, Konstantinidis D, Tatakis F, Drogkaris S, et al
    THE ROLE OF MICROCIRCULATION ON BLOOD PRESSURE AND HEART RATE RESPONSE DURING EXERCISE STRESS TESTING IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  615. YAROVOY S, Chazova I, Danilov N, Matchin Y, et al
    POSITIVE PULMONARY ARTERY REMODELING AFTER A SERIES OF BALLOON PULMONARY ANGIOPLASTIES IN A PATIENT WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  616. PINTO D, Rato ND, Garcia C, Teixeira M, et al
    EFFECTS OF HOME-BASED ISOMETRIC HANDGRIP OR AEROBIC EXERCISE TRAINING IN OLDER ADULTS WITH PRE-HYPERTENSION AND HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  617. MANTA E, Thomopoulos C, Konstantinidis D, Tatakis F, et al
    EFFECT OF DIETARY APPROACHES TO STOP HYPERTENSION DIET OR MEDITERRANEAN DIET ON BLOOD PRESSURE IN INDIVIDUALS WITH OR WITHOUT HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  618. PRATISTITA PTP, Marbun MB
    THE ROLE OF DIETARY APPROACHES TO STOP HYPERTENSION (DASH DIET) ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  619. SPRONCK B, Caulk AW, Ramachandra AB, Murtada SI, et al
    DIFFERENTIAL AORTIC REMODELING EFFECTS OF NOREPINEPHRINE- AND ANGIOTENSIN II-INDUCED HYPERTENSION IN MICE.
    J Hypertens. 2022;40.
    >> Share

  620. MCDERMOTT EA, Mensah EA, Fantin F, Okorie M, et al
    WHITE-COAT HYPERTENSION: SIZE OF THE WHITE-COAT EFFECT IS STRONGLY ASSOCIATED WITH CENTRAL ARTERIAL STIFFNESS.
    J Hypertens. 2022;40.
    >> Share

  621. REKOVETS O, Sirenko Y, Torbas O, Kushnir S, et al
    DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  622. SALADINI F, Rattazzi M, Faggin E, Palatini P, et al
    CAROTID ELASTICITY IS IMPAIRED IN STAGE 1 HYPERTENSIVE PATIENTS EVEN IF BLOOD PRESSURE IS WELL CONTROLLED BY TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  623. THEODORAKOPOULOU M, Alexandrou ME, Iatridi F, Faitatzidou D, et al
    COMPARISON OF AMBULATORY CENTRAL HEMODYNAMICS AND ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS WITH AND WITHOUT INTRADIALYTIC HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  624. JAQUES DA, Vollenweider P, Bochud M, Ponte B, et al
    AGING AND HYPERTENSION IN KIDNEY FUNCTION DECLINE: A 10-YEAR POPULATION-BASED STUDY.
    J Hypertens. 2022;40.
    >> Share

  625. MAHMOUD NB, Hamouda M, Maatoug J, Salem MB, et al
    HYPERTENSION AS A RISK FACTOR FOR MORTALITY AND THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER AN EPISODE OF ACUTE KIDNEY INJURY WITH FULL RECOVERY.
    J Hypertens. 2022;40.
    >> Share

  626. BEZRODNA L, Mishchenko L, Serbenjuk K, Matova O, et al
    EARLY MARKERS OF THE KIDNEYS DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  627. DE LEEUW PW, Houben AJ, Kroon AA
    RENAL EXTRACTION EFFICIENCY FOR PAH IS COMPARABLE IN ESSENTIAL HYPERTENSION AND RENAL FIBROMUSCULAR DYSPLASIA.
    J Hypertens. 2022;40.
    >> Share

  628. HENDRIKS-BALK M, Damianaki A, Polychronopoulou E, Brito W, et al
    RENAL MICROPERFUSION RESPONSE TO A COLD PRESSURE TEST IS DECREASED IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  629. KNEZEVIC T, Padjen I, Laganovic M, Ivkovic V, et al
    TRAJECTORIES OF BLOOD PRESSURE, TREATMENT PATTERNS AND HYPERTENSION CONTROL IN PATIENTS WITH LUPUS NEPHRITIS - DATA FROM A RETROSPECTIVE COHORT STUDY.
    J Hypertens. 2022;40.
    >> Share

  630. LEIBA A, Rappoport V, Hausmann M
    ACUTE RENAL FAILURE PROGRESSING TO ESRD IN A PATIENT WITH UNTREATED HIGH GRADE HYPERTENSION - THE MALIGNANT NATURE OF "BENIGN'' NEPHROSCLEROSIS.
    J Hypertens. 2022;40.
    >> Share

  631. MARTINEZ-ARROYO O, Ortega A, Solaz E, Martinez F, et al
    DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  632. SCHASTLIVENKO A, Vykhrystenka L
    HIGH INCIDENCE OF CHRONIC KIDNEY DISEASE IN THE BELARUSIAN POPULATION PARTICULARLY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  633. DZHURYAK V, Sydorchuk A, Voroniuk K, Sydorchuk L, et al
    ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM INFLUENCES RISK OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  634. TAKENAKA T
    CENTRAL AND BRACHIAL PULSE PRESSURE PREDICTS CARDIOVASCULAR AND RENAL EVENTS IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  635. ANNA M, Alexandru C, Marcel A, Nicolae C, et al
    THE EFFECT OF RENAL DENERVATION ON THE CIRCADIAN BLOOD PRESSURE PATTERN IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  636. FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
    FEATURES OF CHANGES IN THE LEVELS OF MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION AFTER RENAL DENERVATION.
    J Hypertens. 2022;40.
    >> Share

  637. FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
    THE EFFECT OF RENAL DENERVATION ON CEREBRAL BLOOD FLOW IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  638. FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
    THE EFFECT OF RENAL DENERVATION ON PERIPHERAL AND CEREBRAL VASOREACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  639. MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
    LEPTIN AS A PREDICTOR OF CARDIOPROTECTIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  640. BOUHANICK B, Amar J, Amar L, Courand PY, et al
    ANTIPLATELET AND ANTICOAGULANT THERAPY DURING ANGIOPLASTY PROCEDURES FOR ATHEROMATOUS OR FIBROMUSCULAR DYSPLASIA RENAL ARTERY STENOSIS: A SURVEY OF PRACTICES IN EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (ESH-EC) IN FRANCE.
    J Hypertens. 2022;40.
    >> Share

  641. YOUSSEF G, Mesalm MH, Reda G, Bakhoum S, et al
    EFFECT OF AN ELECTRO-STIMULATOR DEVICE ON THE AVERAGE 24-HOUR BLOOD PRESSURE IN PATIENTS WITH MILD AND MODERATE HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  642. ZHIPENG Z, Xiaoping C
    PATIENT PREFERENCE FOR RENAL DENERVATION THERAPY IN HYPERTENSION: A CROSS-SECTIONAL SURVEY IN CHENGDU, CHINA.
    J Hypertens. 2022;40.
    >> Share

  643. ZHAO S, Yu S, Tang J, Maimaitiaili R, et al
    INFLAMMATORY MARKERS AND HYPERTENSION-MEDIATED ORGAN DAMAGE IN COMMUNITY-DWELLING ELDERLY INDIVIDUALS: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2022;40.
    >> Share

  644. HAJRI SE, Messaoudi Y, Ernez S, Bouraoui H, et al
    LONGITUDINAL LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE SUBJECTS WITH NORMAL EJECTION FRACTION: NEW INSIGHT BY SPECKLE TRACKING ECHOCARDIOGRAPHY.
    J Hypertens. 2022;40.
    >> Share

  645. FARHAN HA, Ybeer HF
    GLOBAL LOGITUDINAL STRAIN IN HYPERTENSIVE DISORDERS DURING PREGNANCY AS A PREDICTOR FOR EARLY DETECTION OF SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION.
    J Hypertens. 2022;40.
    >> Share

  646. HENDRIKS-BALK M, Da Costa S, Polychronopoulou E, Damianaki K, et al
    DIFFERENCES IN BOLD MRI SIGNAL INTENSITY BETWEEN HYPERTENSIVE PATIENTS AND HEALTHY VOLUNTEERS.
    J Hypertens. 2022;40.
    >> Share

  647. KOCIANOVA E, Kamasova M, Hanajikova B, Jelinek L, et al
    LEFT ATRIAL VOLUME INDEX (LAVI) AS A PREDICTOR OF PAROXYSMAL ATRIAL FIBRILLATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  648. LIU Y, Sun Q, Fu T, Pan Y, et al
    THE IMPACT AND INTERACTION OF METABOLIC ELEMENTS ON LEFT ATRIAL STIFFNESS IN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  649. OUABDESSELAM S, Mokhtar OA, Bendiab NTS, Henaoui L, et al
    THE TRIGLYCERIDE- GLUCOSE INDEX: AN INDEPENDENT FACTOR OF A SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  650. SHAVAROV A, Kobalava Z
    DISSOCIATION BETWEEN LEFT ATRIAL AND LEFT VENTRICULAR CHANGES IN HYPERTENSIVE PATIENTS WITH ATRIAL CARDIOMYOPATHY.
    J Hypertens. 2022;40.
    >> Share

  651. BENDIAB NT, Henaoui L, Benkhedda S
    HYPERTENSIVE HEART DISEASE, WHAT ARE THE FACTORS PRECIPITATING ITS EARLY ONSET?
    J Hypertens. 2022;40.
    >> Share

  652. ZERVAKIS S, Marketou M, Danelatos C, Maragkoudakis S, et al
    RIGHT VENTRICULAR LONGITUDINAL SYSTOLIC STRAIN AS A PREDICTION MARKER OF NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  653. KRAMER T, Hoenemann J, Weis H, Jordan J, et al
    EFFECTS OF ACUTE NORMOBARIC HYPOXIA-INDUCED PULMONARY HYPERTENSION ON ELECTROCARDIGRAPHIC MEASURES IN POST-MYOCARDIAL INFARCTION PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  654. EZHOVA N, Bazdyreva E, Shavarova E, Khomova I, et al
    LEFT ATRIAL RESERVOIR FUNCTION DECLINES IN HYPERTENSIVE SUBJECTS WITH DYSLIPIDEMIA.
    J Hypertens. 2022;40.
    >> Share

  655. PAFFER MT, Paffer PT, Procopio A, Ribeiro F, et al
    RENAL SYMPATHETIC DENERVATION AS TREATMENT FOR REFRACTORY HYPERTENSION: CASE REPORT.
    J Hypertens. 2022;40.
    >> Share

  656. VRIZ O, Rudski L, Frumento P, Limongelli G, et al
    RIGHT HEART PULMONARY CIRCULATION UNIT RESPONSE TO EXERCISE IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION. INSIGHTS FROM THE RIGHT-NET STUDY.
    J Hypertens. 2022;40.
    >> Share

  657. RIBEIRO C, Neiva R, Silva D, Correia-De-Sa P, et al
    REDUCTION OF HEART RATE VIA P2X4 RECEPTOR ACTIVATION AS A PROMISING TREATMENT STRATEGY IN PULMONARY ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  658. ABDULLAEVA G, Kevorkov A, Yusupova K, Khamidullaeva G, et al
    THE RELATIONSHIP OF ARTERIAL AND MYOCARDIAL STIFFNESS WITH LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  659. SAHOO SK, Pathni AK, Krishna A, Sharma B, et al
    ESTIMATES ON MEDICATION COST OF DRUG DOSE SPECIFIC TREATMENT PROTOCOL FOR HYPERTENSION MANAGEMENT IN PUBLIC AND PRIVATE HEALTHCARE SECTORS IN INDIA.
    J Hypertens. 2022;40.
    >> Share

  660. OUAIL DE, Tebbani M, Bouali F
    THE CHRONOLOGY OF ONSET OF TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  661. LEE HY
    CLINICAL CHARACTERISTICS AND OUTCOME OF KOREAN HYPERTENSION COHORT.
    J Hypertens. 2022;40.
    >> Share

  662. MEAZZA R, Rossi M, Guareschi A, Iaci G, et al
    VASCULAR OR CARDIAC? DIFFERENT TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  663. FLORIDO CF, Pierin AMG
    COHORT STUDY IN PATIENTS WITH HYPERTENSIVE CRISIS: CHARACTERISTICS AND FOLLOW-UP AFTER 30 DAYS.
    J Hypertens. 2022;40.
    >> Share

  664. MAMDOUH H, Alnakhi W, Hussain H, Ibrahim G, et al
    PREVALENCE AND ASSOCIATED RISK FACTORS OF HYPERTENSION AND PRE-HYPERTENSION AMONG THE ADULT POPULATION: FINDINGS FROM THE DUBAI HOUSEHOLD SURVEY, 2019.
    J Hypertens. 2022;40.
    >> Share

  665. STEFFEN HM, Nhlema A, Phiri S, Kasper P, et al
    PREVALENCE AND INCIDENCE OF ARTERIAL HYPERTENSION OVER 36 MONTHS IN AMBULATORY HIV INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY IN LILONGWE, MALAWI.
    J Hypertens. 2022;40.
    >> Share

  666. CONG DT, Ngoc HC
    HEALTH-RELATED QUALITY OF LIFE AND ASSOCIATED FACTORS AMONG HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  667. CRUZ PV, Ang W, Calatrava J
    EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN (LCZ696) IN HYPERTENSION CONTROL AND ADVERSE CARDIOVASCULAR EVENT REDUCTION AMONG ASIANS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  668. ZHANG W, Liu CY, Bilo G, Soranna D, et al
    EFFICACY AND SAFETY OF NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM VERSUS RAMIPRIL IN CHINESE AND EUROPEAN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  669. GALLO G, Forte M, Tocci G, Cotugno M, et al
    ASSOCIATION OF NDUFC2 POLYMORPHIC VARIANTS WITH LEFT VENTRICULAR HYPERTROPHY IN HUMAN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  670. OTMANE A, Makrelouf M, Zenati A
    APO E GENE POLYMORPHISM (C112R, R158C) AND LIPID PROFILE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  671. ANDELOVA K, Bacova BS, Sykora M, Pavelka S, et al
    SPONTANEOUSLY HYPERTENSIVE RATS EXHIBIT ENHANCED CARDIAC CONNEXIN-43 AND REDUCED PRO-FIBROTIC MARKERS IN RESPONSE TO COLD ACCLIMATION.
    J Hypertens. 2022;40.
    >> Share

  672. CAMARGO L, Samji S, Lilla S, Zanivan S, et al
    PROTEOMIC PROFILE OF CYSTEINE OXIDATION IN VASCULAR SMOOTH MUSCLE CELLS IN HUMAN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  673. NAWRES BT, Sabra A, Meriem BS, Manel BS, et al
    POST PARTUM HYPERTENSIVE EMERGENCY REVEALING ATYPICAL HEMOLYTIC AND URAEMIC SYNDROME IN TWO SISTERS.
    J Hypertens. 2022;40.
    >> Share

  674. PODPALOVA O, Kaliadka M, Babenka A, Mrochek A, et al
    TELOMERE LENGTH IS NEGATIVELY ASSOCIATED WITH BMI, R WAVE IN AVL AND IL-6 LEVEL IN PATIENTS WITH NEW CASES OF HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  675. REPCHUK Y
    OBESITY AND VITAMIN D RECEPTOR (VDR, RS2228570) GENE POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  676. REPCHUK Y, Sydorchuk L, Semianiv M, Voronyuk K, et al
    THE CHANGES IN VITAMIN D AND IONIZED CALCIUM LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION DEPENDING ON THE AGT GENE (RS699) POLYMORPHISM.
    J Hypertens. 2022;40.
    >> Share

  677. SEMIANIV M
    25(OH)D AS A RISK FACTOR OF ESSENTIAL ARTERIAL HYPERTENSION CONSIDERING THE GENES POLYMORPHISM AGTR1 (RS5186) AND VDR (RS2228570).
    J Hypertens. 2022;40.
    >> Share

  678. SHORIKOVA D, Shorikov E, Shorikov P, Ismael O, et al
    POLYMORPHISMS NOS3-T-786C IN MACROANGIOPATHIES IN PATIENTS WITH COMBINED HYPERTENSION AND TYPE DIABETES MELLITUS 2.
    J Hypertens. 2022;40.
    >> Share

  679. STRAUSS-KRUGER M, Kruger R, Vuren EJV, Jacobs A, et al
    IDENTIFYING A METABOLOMICS PROFILE ASSOCIATED WITH MASKED HYPERTENSION IN TWO INDEPENDENT COHORTS: DATA FROM THE AFRICAN-PREDICT AND SABPA STUDIES.
    J Hypertens. 2022;40.
    >> Share

  680. SYDORCHUK A, Voroniuk K, Sydorchuk L, Semianiv M, et al
    LINKAGE BETWEEN NOS3 (RS2070744) AND GNB3 (RS5443) GENES' POLYMORPHISM, CAROTID ARTERIES STRUCTURAL CHANGES AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  681. SYDORCHUK A, Voronyuk K, Sydorchuk L, Repchuk Y, et al
    ARE METABOLIC DISORDERS IN HYPERTENSIVE PATIENTS ASSOCIATED WITH GNB3 (RS5443) GENETIC POLYMORPHISMS?
    J Hypertens. 2022;40.
    >> Share

  682. DZHURYAK V, Sydorchuk L, Repchuk Y, Semianiv M, et al
    DEPENDENCE OF METABOLIC DISORDERS ON ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  683. DZHURYAK V, Sydorchuk A, Sydorchuk L, Sydorchuk R, et al
    ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE POLYMORPHISM (894G>T, 786T>C) CONTRIBUTE TO HYPERTENSION RISK AND LIPIDS PROFILE DISORDERS.
    J Hypertens. 2022;40.
    >> Share

  684. ALGHAMDI R, Muhammad F, Osman H, Salim F, et al
    THE PHARMACOKINETIC PARAMETERS DATA OF THE 20 MOST COMMONLY PRESCRIBED ANTIHYPERTENSIVE MEDICATIONS.
    J Hypertens. 2022;40.
    >> Share

  685. ARTEMIEVA M, Biriukova N, Kuropatkina T, Medvedeva N, et al
    GONADOECTOMY REDUCED THE DEGREE OF DEVELOPMENT OF RENOVASCULAR HYPERTENSION IN FEMALE RATS CAUSED BY STOP OF HIGH-SALT DIET.
    J Hypertens. 2022;40.
    >> Share

  686. MAZZA A, Bregola G, Cavazzin E, Dell'avvocata F, et al
    COST-EFFECTIVENESS OF POLYPILL TREATMENT IN HIGH-RISK HYPERTENSIVE SUBJECTS WITH HYPER-CHOLESTEROLAEMIA.
    J Hypertens. 2022;40.
    >> Share

  687. SYKORA M, Kratky V, Tribulova N, Kopkan L, et al
    INHIBITION OF RAS COMPONENTS ATTENUATES PROGRESSION OF MYOCARDIAL REMODELING IN BOTH NORMOTENSIVE AND HYPERTENSIVE RATS IN EXPERIMENTAL HEART FAILURE.
    J Hypertens. 2022;40.
    >> Share

  688. VARBIRO S, Josvai A, Hetthessy J, Matrai M, et al
    ADDITIVE DAMAGE IN THE CONTRACTILITY OF INTRAMURAL CORONARY ARTERIOLES IN A RAT MODEL OF ANDROPAUSAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  689. BENDOUDOUCH H, Dahmani I, Mahdi Z, Benali M, et al
    RESTING ELECTROCARDIOGRAM ABNORMALITIES IN PATIENTS WITH ARTERIAL HYPERTENSION AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS.
    J Hypertens. 2022;40.
    >> Share

  690. ABDREBBI SB, Meguenni K
    EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN A UNIVERSITY HOSPITAL CENTER IN NORTH-WEST OF ALGERIA.
    J Hypertens. 2022;40.
    >> Share

  691. ABDREBBI SB, Meguenni K
    HYPERTENSION, THE MAIN RISK FACTOR FOR STROKE IN A UNIVERSITY HOSPITAL CENTER IN NORTHWEST ALGERIA.
    J Hypertens. 2022;40.
    >> Share

  692. RUF R, Grinshtein Y, Shabalin V
    A COMBINATION OF HYPERTENSION AND A HIGH ATHEROGENIC INDEX OF PLASMA AS AN INDICATOR OF A CORONARY HEART DISEASE RISK.
    J Hypertens. 2022;40.
    >> Share

  693. RUF R, Grinshtein Y, Shabalin V
    THE INTERRELATION OF HYPERTENSION AND HYPERURICEMIA THE PRISM OF SCORE2.
    J Hypertens. 2022;40.
    >> Share

  694. BENTZEL S, Ohman O, Abdulla K, Manhem K, et al
    HIGH BLOOD PRESSURE IN THE EMERGENCY DEPARTMENT. A TOOL FOR DETECTION OF HYPERTENSION? A FOLLOW-UP STUDY OF UNSELECTED PATIENTS ATTENDING AN EMERGENCY DEPARTMENT.
    J Hypertens. 2022;40.
    >> Share

  695. BIRULINA Y, Buyko E, Ivanov V, Dzyuman A, et al
    MORPHOFUNCTIONAL ABNORMALITIES WITHIN THE AORTA AS A PREDICTOR OF ARTERIAL HYPERTENSION IN METABOLIC SYNDROME.
    J Hypertens. 2022;40.
    >> Share

  696. SHAMSUDDIN S, Davis K, Moorhouse L, Mandizvidza P, et al
    ASSOCIATION BETWEEN PSYCHOLOGICAL DISTRESS AND LATER REPORTS OF HYPERTENSION AMONG ADULTS IN EAST ZIMBABWE.
    J Hypertens. 2022;40.
    >> Share

  697. EASON S, Sayers M
    A COMPARISON OF EUROPEAN AND AMERICAN GUIDELINES TO GAUGE THE PREVALENCE OF HYPERTENSION IN 16-19 YEAR OLD BLOOD DONORS.
    J Hypertens. 2022;40.
    >> Share

  698. FRKANEC S, Katic L, Strbac T, Trobonjaca A, et al
    ELECTROCARDIOGRAM CHANGES IN PREHYPERTENSIVE SUBJECTS - EPIDEMIOLOGY OF HYPERTENSION IN CROATIA-1 (EH UH-1) STUDY.
    J Hypertens. 2022;40.
    >> Share

  699. FRKANEC S, Katic L, Strbac T, Tarnovski L, et al
    EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY) -ECG FINDINGS AND CARDIOVASCULAR MORTALITY DATA AFTER 17 YEARS OF FOLLOW-UP.
    J Hypertens. 2022;40.
    >> Share

  700. VARETA G, Georgianos P, Vaios V, Sgouropoulou V, et al
    PREVALENCE, PHENOTYPES AND CONTROL OF HYPERTENSION IN END-STAGE KIDNEY DISEASE PATIENTS UNDERGOING PERITONEAL DIALYSIS.
    J Hypertens. 2022;40.
    >> Share

  701. GEORGIANOU E, Markakis K, Georgianos P, Zografou I, et al
    PREVALENCE AND CONTROL OF HYPERTENSION IN DIABETIC PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  702. LEROUX D, Cloutier L
    GEOGRAPHICAL ANALYSIS OF HYPERTENSION IN CANADIAN POPULATION.
    J Hypertens. 2022;40.
    >> Share

  703. LEWANDOWSKA K, Lipski D, Pawlak-Chomicka R, Uruski P, et al
    THE PREVALENCE OF WHITE-COAT EFFECT AND REVERSE WHITE-COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  704. MIRADA M, Pessana F, Acuna MIR, Ramirez A, et al
    ARTERIAL HYPERTENSION (HT) IS ONE OF THE MOST PREDICTIVE RISK FACTORS FOR TYPE 2 DIABETES (DM2). THE FINDRISC IS VALIDATED FOR THE EARLY DETECTION OF SUFFERING FROM DM2.
    J Hypertens. 2022;40.
    >> Share

  705. MOURAD JJ, Jamet P, Huguet M, Bourbia S, et al
    ANTIHYPERTENSIVE TREATMENT PRESCRIBING BEHAVIOURS IN FRENCH GENERAL PRACTICE IN 2021.
    J Hypertens. 2022;40.
    >> Share

  706. PALMU J, Tikkanen E, Havulinna AS, Vartiainen E, et al
    COMPREHENSIVE BIOMARKER PROFILING OF HYPERTENSION IN 36,985 FINNISH INDIVIDUALS.
    J Hypertens. 2022;40.
    >> Share

  707. REPCHUK Y, Sydorchuk L
    LIPIDS' METABOLISM AND ANGIOTENSINOGEN GENE (AGT, RS699) POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  708. DE PAULA ARAUJO T, Borges LGS, Barroso WKS, Batista SR, et al
    WHAT ARE THE FACTORS ASSOCIATED WITH UNCONTROLLED BLOOD PRESSURE IN BRAZILIAN HYPERTENSIVE PATIENTS?
    J Hypertens. 2022;40.
    >> Share

  709. SHIN JH, Kim BS, Kim HJ, Yu MY, et al
    IMPACT OF THE ESTIMATED GLOMERULAR FILTRATION RATE ON LONG-TERM MORTALITY IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENT.
    J Hypertens. 2022;40.
    >> Share

  710. SHIN JH, Kim BS, Kim HJ, Yu MY, et al
    IMPACT OF PROTEINURIA ON LONG-TERM MORTALITY IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENT.
    J Hypertens. 2022;40.
    >> Share

  711. SHIN JH, Kim BS, Kim W, Kim HJ, et al
    CLINICAL IMPLICATIONS OF CARDIAC TROPONIN-I IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENTS.
    J Hypertens. 2022;40.
    >> Share

  712. TARNOVSKI L, Frkanec S, Katic L, Strbac T, et al
    POOR HYPERTENSION CONTROL AND DISAPPEARANCE OF MEDITERRANEAN LIFE STYLE ON THE CROATIAN ADRIATIC ISLANDS. HUNT ON THE SILENT KILLER (HSK) - OPPORTUNISTIC PUBLIC HEALTH ACTION.
    J Hypertens. 2022;40.
    >> Share

  713. VAY-DEMOUY J, Blacher J, Olie V
    LACK OF LIFESTYLE MODIFICATIONS IN GLOBAL HYPERTENSION MANAGEMENT.
    J Hypertens. 2022;40.
    >> Share

  714. OUAIL DE, Tebbani M, Bouali F
    INTEREST OF MEASURING THE INTIMA MEDIA THICKNESS IN THE EVALUATION OF HYPERTENSIVE.
    J Hypertens. 2022;40.
    >> Share

  715. SYDORCHUK A, Voroniuk K, Sydorchuk L, Repchuk Y, et al
    ENDOTHELIUM DYSFUNCTION PATHWAY AND CAROTID INTIMA-MEDIA THICKNESS IN HYPERTENSIVE PATIENTS: ROLE OF NOS3 (RS2070744) AND GNB3 (RS5443) GENES' POLYMORPHISMS.
    J Hypertens. 2022;40.
    >> Share

  716. YUAN Y, Sun W, Kong X
    COMPARISON BETWEEN DISTINCT INSULIN RESISTANCE INDICES IN MEASURING THE DEVELOPMENT OF HYPERTENSION: THE CHINA HEALTH AND NUTRITION SURVEY.
    J Hypertens. 2022;40.
    >> Share

  717. YUAN Y, Sun W, Kong X
    RELATIONSHIP BETWEEN METABOLICALLY HEALTHY OBESITY AND THE DEVELOPMENT OF HYPERTENSION: A NATIONWIDE POPULATION-BASED STUDY.
    J Hypertens. 2022;40.
    >> Share

  718. CHEN J, Yu J
    MTOR INHIBITOR IMPROVES TESTOSTERONE-INDUCED MYOCARDIAL HYPERTROPHY IN HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  719. VACLAVIK J, Hartmann I, Hruska F, Kocianova E, et al
    HYPERTENSION OUTCOMES OF ADRENALECTOMY FOR UNILATERAL PRIMARY ALDOSTERONISM.
    J Hypertens. 2022;40.
    >> Share

  720. ANDERSSON U, Kjellgren K, Hoffmann M, Wennersten A, et al
    PERSON-CENTREDNESS IN HYPERTENSION MANAGEMENT USING INFORMATION TECHNOLOGY (PERHIT): A RANDOMISED CONTROLLED TRIAL IN PRIMARY HEALTH CARE.
    J Hypertens. 2022;40.
    >> Share

  721. GIRERD X, Canipel L, Hanon O, Pathak A, et al
    EVALUATION OF A DIGITAL THERAPY FOR UNCONTROLLED HYPERTENSIVE PATIENTS FOLLOWED BY GENERAL PRACTITIONERS IN FRANCE.
    J Hypertens. 2022;40.
    >> Share

  722. MAIMAITIAILI R, Li Y, Zhang Y, Feng T, et al
    SIMPLIFIED REGIMEN FOR THE MANAGEMENT OF HYPERTENSION WITH TELEMEDICINE AND BLOOD PRESSURE SELF-MONITORING (SIMPLE): STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  723. OGBOYE A, Rahman KMJ, Odukwe A, Mobisson N, et al
    DIGITAL INTERVENTIONS TO DRIVE SELF-MANAGEMENT IN PEOPLE WITH HYPERTENSION IN NIGERIA.
    J Hypertens. 2022;40.
    >> Share

  724. JACOBS M, Ogboye A, Mobisson N
    HARNESSING HUMAN-CENTRED DESIGN APPROACHES TO BUILD A CHATBOT FOR PEOPLE LIVING WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  725. ZANINI C, Teixeira D, Pereira D, Sousa ALL, et al
    MUSIC THERAPY WITH HYPERTENSIVE PATIENTS DURING THE PANDEMIC PERIOD - ONLINE MEETINGS AS PART OF MULTIPROFESSIONAL TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  726. PAPAVASILEIOU M, Aravantinos D, Karamanou A, Moustakas G, et al
    PROGNOSTIC VALUE OF THE GLYCOSYLATED HEMOGLOBIN TO THE MACE IN HYPERTENSIVE NON DIABETIC PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  727. DOAN L
    SGLT2I - A POTENTIAL ANTIHYPERTENSIVE AGENT IN HYPERTENSION PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  728. GEORGIANOU E, Markakis K, Georgianos P, Zografou I, et al
    THE ASSOCIATION OF EGFR AND ALBUMINURIA WITH SYSTOLIC HYPERTENSION IN PATIENTS WITH DIABETES.
    J Hypertens. 2022;40.
    >> Share

  729. KOTZE-HORSTMANN L, Hill J, Kengne AP, Peer N, et al
    MANAGEMENT OF DYSLIPIDAEMIA AND HYPERTENSION BY GLYCAEMIC STATUS IN URBAN SOUTH AFRICANS.
    J Hypertens. 2022;40.
    >> Share

  730. PAPADAKIS JA, Ioannou P, Theodorakopoulou V, Papanikolaou K, et al
    INCREASED INCIDENCE OF IMPAIRED FASTING GLUCOSE (IFG) AMONG HYPERTENSIVE PATIENTS NAIVE TO HYPOLIPIDEMIC TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  731. PAPAZOGLOU S, Toutouzas K, Tsioufis K
    DO INCREASED LEVELS OF TRIGLYCERIDES CONSIST AN INDEPENDENT RISK FACTOR DEFINING THE SEVERITY OF CARDIOMYOPATHY IN T2DM PATIENTS WITH KNOWN HYPERTENSION ?
    J Hypertens. 2022;40.
    >> Share

  732. WANG Q, Tian L, Sun R, Qi M, et al
    EFFECTS OF SGLT-2 INHIBITORS ON 24H AMBULATORY BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETIC AND HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  733. CHALAKOVA T, Tsochev K, Yotov Y, Bocheva Y, et al
    ARTERIAL HYPERTENSION IN PATIENTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  734. ZHURAVLYOVA L, Rogachova T, Sokolnikova N, Filonenko M, et al
    THE EFFECT OF DAPAGLIFLOZIN ON THE LEVEL OF SYSTOLIC BLOOD PRESSURE AND GLYCEMIC CONTROL IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES.
    J Hypertens. 2022;40.
    >> Share

  735. FEJES I, Roka R, Abraham G, Varkonyi T, et al
    EFFECT OF HYPERTENSION AND RAS INHIBITORS TO ADULT PATIENTS (OVER 18 YEARS OLD) WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV2) INFECTION WHO WERE ADMITTED TO HOSPital.
    J Hypertens. 2022;40.
    >> Share

  736. LOZADA MC, Medina H Jr, Sucaldito MSF, Santos LE, et al
    ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19).
    J Hypertens. 2022;40.
    >> Share

  737. POLYZOS D, Konstantinidis D, Drogkaris S, Tatakis F, et al
    SURGICAL MASKS AND UNATTENDED BLOOD PRESSURE CHANGES IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  738. STIRBAN R, Grigore C, Dragoi D, Balaceanu B, et al
    PARTICULARITIES OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME, ADMITTED FOR SARS-COV-2 INFECTION TO A CLINICAL EMERGENCY HOSPITAL.
    J Hypertens. 2022;40.
    >> Share

  739. STIRBAN R, Grigore C, Dragoi D, Balaceanu B, et al
    NEW ONSET OF HYPERTENSION IN PATIENTS ADMITTED FOR INFECTION WITH SARS-COV-2 VIRUS.
    J Hypertens. 2022;40.
    >> Share

  740. KYYA Y, Barnett O, Halkevych M, Labinska O, et al
    RED BLOOD CELL COLOUR VARIATION AS A MARKER OF CALCIUM DISTRIBUTION: WHAT ROLE DOES IT HAVE IN HEART FAILURE PATIENTS WITH HYPERTENSION AND LONG COVID?
    J Hypertens. 2022;40.
    >> Share

  741. DENISOVA A, Sivakova O, Solntseva T, Chazova I, et al
    EFFECT OF CORONAVIRUS INFECTION ON PATIENTS WITH CONTROLLED AND UNCONTROLLED ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  742. TSOUTSOULI V, Sachla Z, Efstathiou K, Foutsitsakis D, et al
    COVID-19 RELATED CHANGE IN DAILY LIFE OF HYPERTENSIVE PATIENTS MAY AFFECT HYPERTENSION MANAGEMENT.
    J Hypertens. 2022;40.
    >> Share

  743. RODRIGUES FF, Sa J
    COVID-19 INFECTION AND ARTERIAL HYPERTENSION - A RECIPROCAL INTERACTION?
    J Hypertens. 2022;40.
    >> Share

  744. GAVRILA A
    THE PROGNOSTIC VALUE OF THE BIOLOGICAL PROFILE OF INFLAMMATION AND COAGULATION AT HYPERTENSIVE PATIENTS AFTER COVID-19.
    J Hypertens. 2022;40.
    >> Share

  745. HAZARAPETYAN L, Grigoryan S, Zeveian P
    THE FEATURE OF ATRIAL FIBRILLATION OCCURRENCE AND PROGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION, WHO HAVE UNDERGONE COVID-19.
    J Hypertens. 2022;40.
    >> Share

  746. DELALIC D, Jug J, Varahabhatla V, Prkacin I, et al
    ARTERIAL HYPERTENSION FOLLOWING COVID-19.
    J Hypertens. 2022;40.
    >> Share

  747. KOH JH, Kang MJ
    ASSOCIATION BETWEEN DEPRESSION DISORDER AND INCIDENTAL HYPERTENSION IN COVID 19 POSITIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  748. MAKEEVA T, Zbyshevskaya E, Bitakova F, Erinchek V, et al
    CLINICAL AND MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION DIED OF SARS-COV-2 INFECTION.
    J Hypertens. 2022;40.
    >> Share

  749. MAKEEVA T, Zbyshevskaya E, Bitakova F, Butaev T, et al
    RISK FACTORS FOR POST-COVID-19 SYNDROME DEVELOPMENT IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  750. MONTEALEGRE L, Amador E, Pulido T, Rebolledo R, et al
    FACTORS THAT INFLUENCE THE SURVIVAL RATE IN PATIENTS WITH COVID-19 WITH A PREVIOUS DIAGNOSIS OF HYPERTENSION AND/OR DIABETES: A SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  751. OLIE V, Grave C, Tuppin P, Lesuffleur T, et al
    IMPACT OF THE COVID-19 PANDEMIC ON THE INITIATION OF ANTIHYPERTENSIVE DRUG THERAPY IN FRANCE.
    J Hypertens. 2022;40.
    >> Share

  752. KARIORI M, Fragoulis C, Polyzos D, Leontsinis I, et al
    IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS.
    J Hypertens. 2022;40.
    >> Share

  753. KARIORI M, Fragoulis C, Chrysochoou C, Leontsinis I, et al
    CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  754. VINTILA AM, Horumba M, Miron P, Balan R, et al
    ARTERIAL HYPERTENSION SEVERITY INFLUENCE ON COVID19 SEVERITY AND ICU ADMISSION.
    J Hypertens. 2022;40.
    >> Share

  755. WOJCIECHOWSKA W, Terlecki M, Klocek M, Januszewicz A, et al
    IMPACT OF ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE PHARMACOTHERAPY ON IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS: THE CRACOV-HHS STUDY.
    J Hypertens. 2022;40.
    >> Share

  756. YUFEREVA Y, Shevchenko O, Ginzburg L, Zakirzyanov A, et al
    COVID-19 IMPACT ON THE PREVALENCE OF SUBCLINICAL HYPERTENSION AMONG PRACTICALLY HEALTHY MEDICAL STUDENTS.
    J Hypertens. 2022;40.
    >> Share

  757. JAIN R, Hosseini J, Shoghli R
    COVID19 INFECTION IN CORONARY ARTERY DISEASE WITH DIABETES AND HYPERTENSION IN VALVULAR SURGERY PATIENTS IN TERTIARY HEART CENTRE.
    J Hypertens. 2022;40.
    >> Share

  758. VINTILA AM, Horumba M, Miron P, Balan R, et al
    ARTERIAL HYPERTENSION AND COVID19 IN HOSPITAL MORTALITY.
    J Hypertens. 2022;40.
    >> Share

  759. SOLIMENE MC, Drager L, Bortolotto L
    GENDER-RELATED DIFFERENCES IN CORONARY ARTERY DISEASE IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  760. GHRAB A, Chamtouri I, Louati M, Abdallah W, et al
    SMOKING PARADOX IN HYPERTENSIVE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: 25-YEAR POPULATION-BASED STUDY.
    J Hypertens. 2022;40.
    >> Share

  761. SAKALIDIS A, Dimitriadis K, Dri E, Soulaidopoulos S, et al
    HYPERTENSIVE PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE ARE CHARACTERIZED BY INCREASED SYMPATHETIC NERVOUS SYSTEM ACTIVATION.
    J Hypertens. 2022;40.
    >> Share

  762. SAKALIDIS A, Dimitriadis K, Dri E, Soulaidopoulos S, et al
    ARTERIAL STIFNESS AND SYMPATHETIC OVERDRIVE IN HYPERTENSIVE PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  763. TSYGANKOVA O, Ponkin S, Veretyuk V
    EFFECT OF MOBILE APPLICATIONS FOR PHYSICAL ACTIVITY TRACKING ON EXERCISE TOLERANCE IN PATIENTS WITH HYPERTENSION AND CORONARY ARTERY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  764. PAPAVASILEIOU M, Karamanou A, Moustakas G, Aravantinos D, et al
    PROGNOSTIC VALUE OF THE REMNANT CHOLESTEROL AND OTHER LIPID PARAMETERS TO THE MACE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  765. PAPAVASILEIOU MV, Doumas M, Karamanou A, Moustakas G, et al
    ASSOCIATION OF SERUM URIC ACID LEVELS AND ATHEROMATOSIS OF CAROTID ARTERIES IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  766. DE SOUSA A, Magalhaes FG, da Silva SB, Inuzuka S, et al
    ASSOCIATION BETWEEN THE PRESENCE OF COMORBIDITIES AND CARDIOVASCULAR OUTCOMES IN A HYPERTENSIVE LATIN AMERICAN POPULATION.
    J Hypertens. 2022;40.
    >> Share

  767. DUNAIEVA I, Bilovol O, Knyazkova I, Kirienko O, et al
    THE EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN COMORBID PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  768. FEDORISHINA O, Protasov K, Torunova A
    THE RELATIONSHIPS BETWEEN ANXIETY AND BLOOD PRESSURE DYNAMICS UNDER THE ANTIHYPERTENSIVE TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  769. KRYVOSHEI V, Filippova A
    THE STATE OF ELASTIC PROPERTIES OF ARTERIES IN PATIENTS WITH CHRONIC PANCREATITIS IN COMBINATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  770. NEMCSIK J, Korosi B, Gyongyosi H, Batta D, et al
    SIMILARITIES IN DEPRESSION AND ANXIETY BETWEEN WHITE-COAT AND RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  771. OKPARA C, Mobisson N, Moosa M, Rahman KJ, et al
    THE EFFECT OF A DIGITAL HEALTH INTERVENTION ON THE CONTROL OF HYPERTENSION AMONG PEOPLE LIVING WITH CANCER.
    J Hypertens. 2022;40.
    >> Share

  772. BATISTA SR, Vitorino PVO, Silva RR, Sousa ALL, et al
    CARDIOMETABOLIC MULTIMORBIDITY AND ASSOCIATED FACTORS: THE FIRST BRAZILIAN REGISTRY OF PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  773. SIRENKO O, Kuryata O
    ANDROGEN DEFICIENCY ASSOCIATES WITH INCREASED ADVANCED GLYCATED END PRODUCTS, GALECTIN-3 IN HYPERTENSIVE MEN WITH BENIGN PROSTATIC HYPERPLASIA.
    J Hypertens. 2022;40.
    >> Share

  774. BILALOVA D, Nigmatullina R, Mustafin A
    ROLE OF SEROTONIN AND ITS METABOLITE 5-HIAA IN THE DEVELOPMENT OF PULMONARY HYPERTENSION. NEW APPROACHES TO TREATMENT AND NON-INVASIVE DIAGNOSTICS?
    J Hypertens. 2022;40.
    >> Share

  775. CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
    HYPERTENSION AND ARTERIAL STIFFNESS IN PRETERM CHILDREN AND ADOLESCENTS.
    J Hypertens. 2022;40.
    >> Share

  776. GOULAS I, Evripidou K, Doundoulakis I, Nika T, et al
    PREVALENCE OF MASKED HYPERTENSION IN CHILDREN AND YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  777. KOS M, Mihalj M, Hamidovic N, Dumancic D, et al
    ESTIMATION OF DAILY SALT INTAKE IN CHILDREN WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  778. OBRYCKI L, Pac M, Sarnecki J, Feber J, et al
    VASCULAR AGE IN ADOLESCENTS WITH PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  779. PATERNO CA
    THE IMPORTANCE OF THE SYMPTOMS FOR DIAGNOSING AND TREATING OF HYPERTENSION IN CHILDREN, ADOLESCENTS AND YOUNG-AGED, ASSESSED WITH APPLANATION TONOMETRY.
    J Hypertens. 2022;40.
    >> Share

  780. FERNANDEZ GAP
    HYPERTENSIVE HEART DISEASE IN ADOLESCENCE. PRELIMINARY RESULTS OF THE PESESCAD-HTA STUDY.
    J Hypertens. 2022;40.
    >> Share

  781. SHORT B, Moon K, Larkins NG, Hijazzi S, et al
    ISRADIPINE FOR THE TREATMENT OF ACUTE SEVERE HYPERTENSION IN CHILDREN.
    J Hypertens. 2022;40.
    >> Share

  782. SKRZYPCZYK P, Bujanowicz A, Pawlik K, Wroniewicz T, et al
    MEAN PLATELET VOLUME IS A PREDICTOR OF BLOOD PRESSURE NORMALIZATION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  783. KOLLIAS A, Ntineri A, Zeniodi ME, Stambolliu E, et al
    HYPERTENSION PHENOTYPES IN YOUNG INDIVIDUALS BASED ON COMBINED OR ISOLATED ELEVATION OF OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENTS AND ASSOCIATION WITH ORGAN DAMAGE.
    J Hypertens. 2022;40.
    >> Share

  784. GULKEVYCH O, Mishchenko L, Logvynenko A, Matova O, et al
    COGNITIVE IMPAIRMENT AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH RESISTANCE HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  785. BOULESTREAU R, Lucas L, Cremer A, Doublet J, et al
    NEUROLOGICALLY ASYMPTOMATIC PATIENTS FREQUENTLY PRESENT CEREBRAL INJURIES DURING MALIGNANT HYPERTENSION: A MRI STUDY.
    J Hypertens. 2022;40.
    >> Share

  786. GERMAN-SALLO M, Preg Z, Pal T, Andrassy K, et al
    HEART RATE VARIABILITY AND BRAIN FUNCTIONING IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  787. ULBRICH P, Morton L, Briese M, Lammlin N, et al
    STAGE-DEPENDENT RESPONSES OF VASCULAR AND PARENCHYMAL CELLS IN THE HYPERTENSIVE RAT BRAIN.
    J Hypertens. 2022;40.
    >> Share

  788. WOJCIECHOWSKA E, Gryglas P
    CASE REPORT: HELLP-LIKE SYNDROME IN A 19-YEAR-OLD WOMAN WITH NOT WELL - CONTROLLED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  789. GEORGIEVA N, Kinova E, Borizanova A, Shopov L, et al
    ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  790. LIAKOS C, Karpanou E, Markou M, Grassos C, et al
    SYNERGISTIC EFFECT OF HIGH HOMOCYSTEINE AND LOW VITAMIN B12 LEVELS ON THE PREVALENCE OF ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  791. CHEN J, Yu J
    ASSOCIATION OF FREE ANDROGEN INDEX AND SEX HORMONE BINDING GLOBULIN AND LEFT VENTRICULAR HYPERTROPHY IN POSTMENOPAUSAL HYPERTENSIVE WOMEN.
    J Hypertens. 2022;40.
    >> Share

  792. DUARTE F, Santos I, Barrada MI, Oliveira L, et al
    ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN OBESE HYPERTENSIVE PATIENTS - CAN WE CONSIDER A DIFFERENT APPROACH?
    J Hypertens. 2022;40.
    >> Share

  793. OTMANE A, Makrelouf M, Zenati A
    ASSOCIATION BETWEEN URIC ACID AND METABOLIC SYNDROME IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  794. ABDELHALIM T, Nadia DD, Abdelghani BC
    ARTERIAL HYPERTENSION, THE MOST FREQUENT CARDIOVASCULAR RISK FACTOR, BUT HITHERTO UNRECOGNIZED IN THE NOMADIC POPULATION OF SOUTHERN ALGERIA.
    J Hypertens. 2022;40.
    >> Share

  795. ALI U, Podpalov V
    HIGH LEVEL OF THE AMOUNT OF ECG PEAKS SV1+RV5-V6 PREDICT NEW CASES OF HYPERTENSION IN THE ORGANIZED POPULATION OF THE PETROCHEMICAL INDUSTRY WORKERS.
    J Hypertens. 2022;40.
    >> Share

  796. PAPAVASILEIOU MV, Mytas D, Karamanou A, Moustakas G, et al
    ASSOCIATION OF SERUM URIC ACID WITH LEFT VENTRICLE, LEFT VENTRICULAR FILLING PRESSURE AND LEFT ATRIAL SIZE IN HYPERTENSIVE PATIENTS WITHOUT ATRIAL FIBRILLATION.
    J Hypertens. 2022;40.
    >> Share

  797. BUILA N, Kabanda G, Nkodila A, Mundu G, et al
    IMPACT OF ADAPTED PHYSICAL ACTIVITY ON BLOOD PRESSURE AND HYPERTENSION CONTROL IN MILITARY OF THE KINSHASA GARNISON.
    J Hypertens. 2022;40.
    >> Share

  798. VACCA A, Catena C, Soardo G, Spagnol F, et al
    RELATIONSHIPS BETWEEN NAFLD BIOCHEMICAL SCORES AND LEFT VENTRICULAR GEOMETRIC PATTERN IN NAIVE ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  799. CHINNAAIAH K, Lo FA, Sule AA, Chin TJ, et al
    INCREASE ARTERIAL STIFFNESS IN MOYAMOYA DISEASE PRESENTING WITH HYPERTENSION AND STROKE: A NOVEL FINDING IN A VERY RARE CASE IN SINGAPORE.
    J Hypertens. 2022;40.
    >> Share

  800. DE ROSA ML, Zuccarino M, Di Sarro E, Iovino MD, et al
    THE IMPACT OF POLLUTION ON HYPERTENSION AND ECONOMY.
    J Hypertens. 2022;40.
    >> Share

  801. HAKO Y, Bika C, Okala C, Dissongo JI, et al
    HYPERTENSION IN CAMEROONIAN RURAL AND URBAN PYGMIES AND BANTUS OF THE SOUTHERN REGION.
    J Hypertens. 2022;40.
    >> Share

  802. INUZUKA S, Filho GG, Vitorino P, Barroso A, et al
    CARDIOVASCULAR RISK RECLASSIFICATION BY PULSE WAVE VELOCITY IN BRAZILIAN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  803. KLAUS KK, Lukas K, Bernhard G, Jutta S, et al
    INCREASED IONIZED CALCIUM-MAGNESIUM-RATIO IN ELDERLY HYPERTENSIVES - RELATIONSHIP TO ARTHERIOSCLEROSIS.
    J Hypertens. 2022;40.
    >> Share

  804. LI Y, Xinhua T, Xiaoling X, Guoxiong C, et al
    COMPARISON OF HYPERTENSION PREVALENCE AND ASSOCIATED RISK FACTORS IN MONKS AND COMMON RESIDENTS FROM ZHEJIANG PROVINCE, SOUTHEAST CHINA.
    J Hypertens. 2022;40.
    >> Share

  805. MALOBERTI A, Fumagalli S, Garofani I, Ghidini S, et al
    RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  806. NAZ Q, Verma N, Serajuddin M, Patel ML, et al
    ALPHA ADDUCIN GENE POLYMORPHISM IS MORE COMMON IN MALE AS COMPARE TO FEMALE IN ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  807. OOI IJ, Chia YC
    PREVALENCE AND RISK FACTORS OF POSTURAL HYPOTENSION AMONG HYPERTENSIVE PATIENTS IN A PRIMARY CARE SETTING.
    J Hypertens. 2022;40.
    >> Share

  808. LONG NP, Kim NHT
    STUDYING THE SITUATION OF CAROTID ATHEROSCLEROSIS OF HYPERTENSIVE PATIENTS IN THE NORTH OF BINH DINH PROVINCE VIETNAM 2019.
    J Hypertens. 2022;40.
    >> Share

  809. SAFRONENKO V, Chesnikova A, Sementsova N, Skarzhinskaya N, et al
    INFLUENCE OF CONCOMITANT ATHEROSCLEROSIS OF THE ARTERIES OF THE LOWER EXTREMITIES ON THE PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  810. SEMIANIV M, Sydorchuk L, Biletsky S, Petrynych O, et al
    LIPID DISORDERS AND ESSENTIAL ARTERIAL HYPERTENSION RISK DEPENDING ON AGTR1 (RS5186) AND VDR (RS2228570) GENES POLYMORPHISM.
    J Hypertens. 2022;40.
    >> Share

  811. SURUNOVICH J, Podpalov V
    HYPERTENSION AND COMORBIDITY AS MACE DEVELOPMENT RISK FACTORS IN THE EAST EUROPEAN REGION.
    J Hypertens. 2022;40.
    >> Share

  812. BACOVA BS, Benova TE, Sykora M, Zurmanova J, et al
    CONTINUOUS EXPOSURE OF THE HYPERTENSIVE RATS TO LIGHT INCREASES THE RISK OF MALIGNANT CARDIAC ARRHYTHMIAS - OMACOR CARDIOPROTECTION.
    J Hypertens. 2022;40.
    >> Share

  813. TRIANTAFYLLIDI H, Benas D, Fabri A, Birmpa D, et al
    SMOKING HABIT IS NOT RELATED WITH HYPERTENSION MEDIATED ORGAN DAMAGE IN YOUNG PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  814. TRIANTAFYLLIDI H, Birmpa D, Benas D, Fabri A, et al
    ISOLATED DIASTOLIC HYPERTENSION IS NOT A BENIGN SITUATION REGARDING HYPERTENSION MEDIATED ORGAN DAMAGE IN PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  815. TRIANTAFYLLIDI H, Fabri A, Benas D, Birmpa D, et al
    REDUCED ENDOTHELIAL GLYCOCALYX IS ASSOCIATED WITH HYPERTENSION BURDEN ONLY IN MALE SMOKERS WITH FIRST DIAGNOSED AND NEVER TREATED STAGE I AND II ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  816. TRIANTAFYLLIDI H, Vlachos S, Benas D, Fabri A, et al
    HEPATIC STEATOSIS INDEX IS INDEPENDENTLY RELATED TO HYPERTENSION MEDIATED ORGAN DAMAGE IN PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION AND SMOKING HABIT.
    J Hypertens. 2022;40.
    >> Share

  817. SIAFI E, Andrikou I, Thomopoulos C, Konstantinidis D, et al
    THE PROGNOSTIC VALUE OF FATTY LIVER INDEX FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  818. KAKOURI N, Andrikou I, Konstantinidis D, Siafi E, et al
    SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    J Hypertens. 2022;40.
    >> Share

  819. WANG Q, Zhang H, Wang W, Fan X, et al
    EFFECT OF HYPOKALEMIA ON LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  820. WANG Q, Zhang H, Wang W, Pei Y, et al
    STUDY ON HYPERTENSION-RELATED TARGET ORGAN DAMAGE IN ESSENTIAL HYPERTENSION PATIENTS WITH HYPOKALEMIA.
    J Hypertens. 2022;40.
    >> Share

  821. WOZNICKA-LESKIEWICZ L, Posadzy-Malaczynska A
    CARDIOVASCULAR RISK AND SUBCLINICAL VASCULAR ORGAN DAMAGE IN PATIENTS WITH AND WITHOUT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  822. LI C, Wang Q, Ma L, Wang W, et al
    RHO KINASE BLOCKADE ALLEVIATE BLOOD PRESSURE ELEVATION AND INHIBIT VASCULAR REMODELING IN APATINIB-INDUCED HYPERTENSION-TO BE CONFERMED.
    J Hypertens. 2022;40.
    >> Share

  823. LI C, Wang Q, Ma L, Wang W, et al
    RHO KINASE BLOCKADE ALLEVIATE BLOOD PRESSURE ELEVATION AND INHIBIT VASCULAR REMODELING IN APATINIB-INDUCED HYPERTENSION TO BE CONFERMED.
    J Hypertens. 2022;40.
    >> Share

  824. VAN DORST D, Colafella KM, Van Doorn L, Van Veghel R, et al
    CYCLOOXYGENASE-2 INHIBITION AS A NEW TOOL TO COMBAT ANGIOGENESIS INHIBITOR-INDUCED HYPERTENSION AND RENAL TOXICITY.
    J Hypertens. 2022;40.
    >> Share

  825. WANG W, Zhan H, Wang Q, Zhuang C, et al
    RHOA/ROCK PATHWAY PARTICIPATES IN THE STUDY OF RELATED MECHANISMS OF APATINIB IN THE TREATMENT OF BREAST CANCER-INDUCED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  826. FERREIRA MJ, Silva GDC, Bernardes N, De Araujo AA, et al
    DIURETIC ASSOCIATED WITH CONCURRENT EXERCISE PROMOTES ADDITIONAL PHYSICAL, AUTONOMIC AND INFLAMMATORY ADAPTATIONS IN HYPERTENSIVE RATS SUBMITTED TO OVARIAN HORMONE PRIVATION.
    J Hypertens. 2022;40.
    >> Share

  827. BILO G, Kyriakoulis K, Liu CY, Soranna D, et al
    EFFECT OF NIFEDIPINE GITS OR RAMIPRIL ON BLOOD PRESSURE VARIABILITY IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTS: RESULTS OF REVERENT RANDOMIZED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  828. ILIC MD, Stojanovic S, Krstic I, Stojanovic M, et al
    ASSOCIATION BETWEEN VARIABILITY IN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS: 60 MONTHS FOLLOW UP.
    J Hypertens. 2022;40.
    >> Share

  829. KERRIDGE T, Gupta A
    NOCTURNAL DIPPING PATTERN IN 24-HOUR AMBULATORY BLOOD PRESSURE RECORDINGS OF HYPERTENSIVE INDIVIDUALS IN THE BAY OF PLENTY (BOP).
    J Hypertens. 2022;40.
    >> Share

  830. KEZHUN L
    EFFECT OF CHOLECALCIFEROL ON RATE OF MORNING BLOOD PRESSURE RISE IN WOMEN WITH ARTERIAL HYPERTENSION IN PREMENOPAUSAL AND EARLY POSTMENOPAUSAL PERIODS.
    J Hypertens. 2022;40.
    >> Share

  831. LIN Z, Zhang YH
    ISCHEMIC REPERFUSION INJURY IN HYPERTENSIVE RAT HEART.
    J Hypertens. 2022;40.
    >> Share

  832. MOJAAT M, Ben Salah M, Salem MB, Handous I, et al
    HYPERTENSION FOLLOWING LIVING KIDNEY-DONATION: BETTER SAFE THAN SORRY. A SINGLE-CENTER STUDY.
    J Hypertens. 2022;40.
    >> Share

  833. SILVA S, Sousa AC, Sousa AL, Vitorino P, et al
    BEHAVIOR OF PRESSURE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES MELLITUS WITH OR WITHOUT INSULIN USE AND THE INFLUENCE OF THE NUTRITIONAL STATE IN BRAZIL.
    J Hypertens. 2022;40.
    >> Share

  834. SOUSA AC, Magalhaes FG, Silva SB, Simeoni AR, et al
    ASSOCIATION OF SHORT-TERM BLOOD PRESSURE VARIABILITY WITH DIABETES IN HYPERTENSIVE INDIVIDUALS.
    J Hypertens. 2022;40.
    >> Share

  835. KYRIAKOULIS K, Kollias A, Bilo G, Soranna D, et al
    BLOOD PRESSURE VARIABILITY ASSESSED WITH OFFICE, HOME AND AMBULATORY MEASUREMENTS BEFORE AND AFTER ANTIHYPERTENSIVE DRUG TREATMENT: THE REVERENT TRIAL.
    J Hypertens. 2022;40.
    >> Share

  836. KOLLIAS A, Kyriakoulis K, Bilo G, Soranna D, et al
    IDENTIFICATION OF HYPERTENSIVE PATIENTS WITH INCREASED BLOOD PRESSURE VARIABILITY USING DIFFERENT MEASUREMENT METHODS BEFORE AND AFTER TREATMENT: THE REVERENT TRIAL.
    J Hypertens. 2022;40.
    >> Share